| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 1.24e-09 | 11 | 240 | 6 | GO:0098973 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 1.01e-07 | 5 | 240 | 4 | GO:0030156 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 1.98e-06 | 32 | 240 | 6 | GO:0099186 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | PI4K2B ERVK-6 CMPK2 FGFRL1 DGKH ERVK-7 FPGT ERVK-10 TRRAP PI4KA AK5 ERVK-11 GMPPB RPS6KL1 MOS CAD POLRMT NRG2 ERN2 CDC42BPB SIRT4 CASK PRKAG3 LIMK1 PANK4 CARD11 PKN1 LTK POLG2 | 3.12e-06 | 938 | 240 | 29 | GO:0016772 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 4.18e-06 | 21 | 240 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH10 MYH11 ATP8B4 TDRD9 ACTB ACTC1 MCM6 DDX5 DDX46 ACSM3 STARD9 PIF1 VCP KIF22 DNHD1 DDX17 DYNC2H1 RNF213 ATP13A5 MYH14 ACSM2A DNAH11 | 5.42e-06 | 614 | 240 | 22 | GO:0140657 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 6.29e-06 | 11 | 240 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.03e-05 | 42 | 240 | 6 | GO:0098918 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | ERVK-6 TDRD9 GATB ERVK-7 ERVK-10 DDX5 DUS2 DDX46 PAN2 ERVK-11 PIF1 DDX17 POLRMT ERN2 TDP2 FARS2 MARF1 | 1.29e-05 | 417 | 240 | 17 | GO:0140098 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.29e-05 | 118 | 240 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.85e-05 | 14 | 240 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 2.81e-05 | 130 | 240 | 9 | GO:0005200 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 TDRD9 GATB MCM6 ERVK-7 ERVK-10 DDX5 DUS2 DFFB DDX46 PAN2 ERVK-11 PIF1 PLD4 DDX17 POLRMT ERN2 TDP2 FARS2 MARF1 POLG2 | 3.69e-05 | 645 | 240 | 21 | GO:0140640 |
| GeneOntologyMolecularFunction | sulfur compound binding | ACACB CXCL10 FGFRL1 DMBT1 SOAT2 MPO CBS GSS TKT LPL TENM1 ADGRE5 CTSG AGRN | 3.91e-05 | 323 | 240 | 14 | GO:1901681 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 7.66e-05 | 37 | 240 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 8.74e-05 | 38 | 240 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 8.74e-05 | 38 | 240 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 9.52e-05 | 152 | 240 | 9 | GO:0016779 | |
| GeneOntologyMolecularFunction | nuclease activity | ERVK-6 ERVK-7 ERVK-10 DFFB PAN2 ERVK-11 PLD4 POLRMT ERN2 TDP2 MARF1 | 1.16e-04 | 231 | 240 | 11 | GO:0004518 |
| GeneOntologyMolecularFunction | S-acetyltransferase activity | 1.44e-04 | 2 | 240 | 2 | GO:0016418 | |
| GeneOntologyMolecularFunction | nucleoside monophosphate kinase activity | 1.51e-04 | 23 | 240 | 4 | GO:0050145 | |
| GeneOntologyMolecularFunction | carbon-nitrogen ligase activity, with glutamine as amido-N-donor | 1.93e-04 | 10 | 240 | 3 | GO:0016884 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 2.43e-04 | 136 | 240 | 8 | GO:0004540 | |
| GeneOntologyMolecularFunction | ligase activity | 2.64e-04 | 174 | 240 | 9 | GO:0016874 | |
| GeneOntologyMolecularFunction | C-rich single-stranded DNA binding | 4.28e-04 | 3 | 240 | 2 | GO:1990829 | |
| GeneOntologyMolecularFunction | acyltransferase activity | ZZEF1 FBXL21P FASN ACSM3 DLAT SOAT2 UBR2 AMFR ITCH SH3RF1 AGPAT1 RNF213 FBXO11 TRIM71 SIRT4 DGAT2L6 TRIM33 TRIM17 PRKN ACSM2A HERC4 | 4.61e-04 | 775 | 240 | 21 | GO:0016746 |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol 4-kinase activity | 8.50e-04 | 4 | 240 | 2 | GO:0004430 | |
| GeneOntologyMolecularFunction | BAT3 complex binding | 8.50e-04 | 4 | 240 | 2 | GO:1904288 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP8B4 TDRD9 ACTB MCM6 DDX5 DDX46 PIF1 VCP KIF22 DDX17 DYNC2H1 RNF213 ATP13A5 DNAH11 | 9.50e-04 | 441 | 240 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | kinase activity | PI4K2B CMPK2 FGFRL1 DGKH TRRAP PI4KA AK5 RPS6KL1 MOS CAD NRG2 ERN2 CDC42BPB CASK PRKAG3 LIMK1 PANK4 CARD11 PKN1 LTK | 9.62e-04 | 764 | 240 | 20 | GO:0016301 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 9.84e-04 | 37 | 240 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.09e-03 | 38 | 240 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.22e-03 | 18 | 240 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | endonuclease activity | 1.30e-03 | 136 | 240 | 7 | GO:0004519 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 MCM6 ERVK-7 ERVK-10 DFFB ERVK-11 PIF1 PLD4 TDP2 POLG2 | 1.32e-03 | 262 | 240 | 10 | GO:0140097 |
| GeneOntologyMolecularFunction | phosphotransferase activity, phosphate group as acceptor | 1.45e-03 | 41 | 240 | 4 | GO:0016776 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.54e-03 | 70 | 240 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | ubiquitin-specific protease binding | 1.68e-03 | 20 | 240 | 3 | GO:1990381 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ERVK-7 ERVK-10 ERVK-18 ERVK-25 MMP1 MMP23B PRSS33 ADAMTS13 PREP KDM8 CTSG CAPN15 | 2.20e-03 | 430 | 240 | 13 | GO:0004175 |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.24e-03 | 46 | 240 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound kinase activity | 2.42e-03 | 47 | 240 | 4 | GO:0019205 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 5.18e-08 | 31 | 238 | 7 | GO:0098974 | |
| GeneOntologyBiologicalProcess | mesenchyme migration | 8.57e-08 | 5 | 238 | 4 | GO:0090131 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 1.27e-07 | 35 | 238 | 7 | GO:0099188 | |
| GeneOntologyBiologicalProcess | synapse organization | MYH10 ACTBL2 SARM1 ACTB ACTG1 POTEKP SLITRK1 POTEE HMCN2 CASKIN1 TLN2 PLXNB1 VCP POTEF WNT7A WNT7B NRG2 GRIA1 LRRC4C CASK DNAJA3 ADGRE5 AGRN SEMA3E | 1.45e-06 | 685 | 238 | 24 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell junction organization | MYH10 ACTBL2 PECAM1 SARM1 ACTB ACTG1 POTEKP SLITRK1 POTEE CORO2B HMCN2 CASKIN1 PKHD1 TLN2 PLXNB1 VCP POTEF WNT7A WNT7B FRMPD2 NRG2 GRIA1 LRRC4C CASK DNAJA3 ADGRE5 AGRN SEMA3E | 8.51e-06 | 974 | 238 | 28 | GO:0034330 |
| GeneOntologyBiologicalProcess | DNA integration | 1.14e-05 | 13 | 238 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | protein autoubiquitination | 3.28e-05 | 78 | 238 | 7 | GO:0051865 | |
| GeneOntologyBiologicalProcess | axon development | MYH10 ACTBL2 ACTB ACTG1 POTEKP SLITRK1 LRIG2 POTEE HMCN2 MYPN PLXNB1 PLXNA3 POTEF WNT7A WNT7B LRRC4C GRM7 LIMK1 AGRN SEMA3E | 5.96e-05 | 642 | 238 | 20 | GO:0061564 |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | ACACB SARM1 CMPK2 PFAS HMGCR NDUFS2 FASN ACSM3 AK5 GLRX DLAT ALDOA GMPPB VCP CAD CASK PRKAG3 TKT PANK4 PRKN CARD11 ACSM2A | 8.56e-05 | 767 | 238 | 22 | GO:0055086 |
| GeneOntologyBiologicalProcess | axonogenesis | MYH10 ACTBL2 ACTB ACTG1 POTEKP SLITRK1 POTEE HMCN2 MYPN PLXNB1 PLXNA3 POTEF WNT7A WNT7B LRRC4C LIMK1 AGRN SEMA3E | 1.08e-04 | 566 | 238 | 18 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell morphogenesis | MYH10 ACTBL2 PECAM1 SARM1 ACTB ACTG1 POTEKP SLITRK1 POTEE HMCN2 MYPN PKHD1 SCFD1 ALDOA PLXNB1 BRWD1 PLXNA3 SLC11A2 POTEF WNT7A WNT7B LRRC4C CASK YPEL4 LIMK1 MYH14 PRKN AGRN SEMA3E | 1.24e-04 | 1194 | 238 | 29 | GO:0000902 |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | ACACB SARM1 CMPK2 PFAS HMGCR NDUFS2 FASN ACSM3 AK5 DLAT ALDOA VCP CAD CASK PRKAG3 TKT PANK4 PRKN CARD11 ACSM2A | 1.40e-04 | 684 | 238 | 20 | GO:0009117 |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | ACACB SARM1 CMPK2 PFAS HMGCR NDUFS2 FASN ACSM3 AK5 DLAT ALDOA VCP CAD CASK PRKAG3 TKT PANK4 PRKN CARD11 ACSM2A | 1.61e-04 | 691 | 238 | 20 | GO:0006753 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | MYH10 ACTBL2 SARM1 ACTB ACTG1 POTEKP SLITRK1 POTEE HMCN2 MYPN PLXNB1 PLXNA3 SLC11A2 POTEF WNT7A WNT7B LRRC4C CASK LIMK1 PRKN AGRN SEMA3E | 1.62e-04 | 802 | 238 | 22 | GO:0048812 |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | ACACB PFAS HMGCR NDUFS2 FASN ACSM3 AK5 DLAT ALDOA VCP CAD CASK PRKAG3 PANK4 PRKN CARD11 ACSM2A | 1.63e-04 | 533 | 238 | 17 | GO:0009259 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYH10 MYH11 ACTBL2 PECAM1 ACTA1 ACTB ACTC1 ACTG1 POTEKP POTEE CORO2B MYPN TLN2 ALDOA THSD7A POTEF CDC42BPB SYDE1 LIMK1 MYH14 TENM1 PRKN | 1.65e-04 | 803 | 238 | 22 | GO:0030036 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | MYH10 ACTBL2 SARM1 ACTB ACTG1 POTEKP SLITRK1 POTEE HMCN2 MYPN PLXNB1 PLXNA3 SLC11A2 POTEF WNT7A WNT7B LRRC4C CASK LIMK1 AGRN SEMA3E | 1.67e-04 | 748 | 238 | 21 | GO:0048667 |
| GeneOntologyBiologicalProcess | positive regulation of membrane potential | 1.81e-04 | 25 | 238 | 4 | GO:0045838 | |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | ACACB PFAS HMGCR NDUFS2 FASN ACSM3 AK5 DLAT ALDOA VCP CAD CASK PRKAG3 PANK4 PRKN CARD11 ACSM2A | 1.90e-04 | 540 | 238 | 17 | GO:0019693 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | MYH10 ACTBL2 SARM1 ACTB ACTG1 POTEKP SLITRK1 POTEE HMCN2 MYPN PLXNB1 PLXNA3 SLC11A2 POTEF WNT7A WNT7B LRRC4C CASK LIMK1 PRKN AGRN SEMA3E | 2.17e-04 | 819 | 238 | 22 | GO:0120039 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 2.24e-04 | 48 | 238 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | skeletal myofibril assembly | 2.34e-04 | 11 | 238 | 3 | GO:0014866 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | MYH10 ACTBL2 SARM1 ACTB ACTG1 POTEKP SLITRK1 POTEE HMCN2 MYPN PLXNB1 PLXNA3 SLC11A2 POTEF WNT7A WNT7B LRRC4C CASK LIMK1 PRKN AGRN SEMA3E | 2.45e-04 | 826 | 238 | 22 | GO:0048858 |
| GeneOntologyBiologicalProcess | postsynapse organization | MYH10 ACTBL2 ACTB ACTG1 POTEKP POTEE CASKIN1 POTEF WNT7A CASK DNAJA3 AGRN | 2.98e-04 | 313 | 238 | 12 | GO:0099173 |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | ACACB PFAS HMGCR NDUFS2 FASN ACSM3 AK5 DLAT ALDOA VCP CASK PRKAG3 PANK4 PRKN CARD11 ACSM2A | 3.18e-04 | 512 | 238 | 16 | GO:0009150 |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | ACACB SARM1 PFAS HMGCR NDUFS2 FASN ACSM3 AK5 DLAT ALDOA VCP CASK PRKAG3 TKT PANK4 PRKN CARD11 ACSM2A | 3.24e-04 | 619 | 238 | 18 | GO:0006163 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH10 MYH11 ACTBL2 PECAM1 ACTA1 ACTA2 ACTB ACTC1 ACTG1 POTEKP POTEE CORO2B MYPN TLN2 ALDOA THSD7A POTEF CDC42BPB SYDE1 LIMK1 MYH14 TENM1 PRKN | 3.83e-04 | 912 | 238 | 23 | GO:0030029 |
| GeneOntologyBiologicalProcess | nucleoside diphosphate biosynthetic process | 3.98e-04 | 13 | 238 | 3 | GO:0009133 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 3.99e-04 | 83 | 238 | 6 | GO:0006278 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 6.00e-08 | 32 | 238 | 7 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 6.00e-08 | 32 | 238 | 7 | GO:0043189 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH10 MYH11 ACTBL2 ACTA1 ACTA2 ACTB APBB3 ACTC1 ACTG1 ACTG2 DGKH POTEKP KEAP1 POTEE CORO2B TLN2 ALDOA POTEF CDC42BPB CASK DNAJA3 MYH14 DCTN6 | 2.04e-07 | 576 | 238 | 23 | GO:0015629 |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 7.13e-07 | 45 | 238 | 7 | GO:1902562 | |
| GeneOntologyCellularComponent | actin filament | ACTBL2 ACTA1 ACTB ACTC1 ACTG1 POTEKP KEAP1 POTEE POTEF DNAJA3 | 6.94e-06 | 146 | 238 | 10 | GO:0005884 |
| GeneOntologyCellularComponent | smooth muscle contractile fiber | 1.43e-05 | 5 | 238 | 3 | GO:0030485 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 3.55e-05 | 109 | 238 | 8 | GO:1902493 | |
| GeneOntologyCellularComponent | actomyosin | 5.89e-05 | 117 | 238 | 8 | GO:0042641 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.00e-04 | 94 | 238 | 7 | GO:0000123 | |
| GeneOntologyCellularComponent | myosin filament | 1.72e-04 | 25 | 238 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.89e-04 | 104 | 238 | 7 | GO:0031248 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 2.25e-04 | 107 | 238 | 7 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 2.25e-04 | 107 | 238 | 7 | GO:0001725 | |
| GeneOntologyCellularComponent | axon | MYH10 TSPOAP1 ACTBL2 SARM1 ACTB ACTG1 POTEKP SEPTIN6 LRIG2 POTEE HMCN2 MYPN AMFR CAD DRD4 POTEF GRIA1 GRM7 SYDE1 LIMK1 MYH14 PRKN AGRN | 2.28e-04 | 891 | 238 | 23 | GO:0030424 |
| GeneOntologyCellularComponent | intracellular protein-containing complex | ACTBL2 ACTB GATB ACTG1 POTEKP KEAP1 TRRAP FBXL21P POTEE VCP UBR2 AMFR ITCH ZSWIM5 POTEF UBXN8 POLRMT FBXO11 CEP164 PRKAG3 GTF2F2 PRKN CARD11 POLG2 | 3.20e-04 | 972 | 238 | 24 | GO:0140535 |
| GeneOntologyCellularComponent | brush border | 3.60e-04 | 152 | 238 | 8 | GO:0005903 | |
| GeneOntologyCellularComponent | myosin II filament | 3.84e-04 | 3 | 238 | 2 | GO:0097513 | |
| GeneOntologyCellularComponent | podocyte foot | 3.84e-04 | 3 | 238 | 2 | GO:0098846 | |
| GeneOntologyCellularComponent | actin filament bundle | 4.10e-04 | 118 | 238 | 7 | GO:0032432 | |
| GeneOntologyCellularComponent | distal axon | MYH10 TSPOAP1 ACTB ACTG1 SEPTIN6 LRIG2 AMFR CAD DRD4 GRM7 LIMK1 MYH14 PRKN AGRN | 4.93e-04 | 435 | 238 | 14 | GO:0150034 |
| GeneOntologyCellularComponent | cell-substrate junction | EPPK1 ACTB RPS11 ACTC1 ACTG1 KEAP1 CORO2B PI4KA TLN2 CASK LIMK1 ADGRE5 IL1RL1 PCBP2 | 5.90e-04 | 443 | 238 | 14 | GO:0030055 |
| GeneOntologyCellularComponent | cleavage furrow | 6.49e-04 | 61 | 238 | 5 | GO:0032154 | |
| GeneOntologyCellularComponent | transferase complex | ACACB ACTBL2 ACTB ACTG1 POTEKP KEAP1 TRRAP FBXL21P POTEE DLAT UBR2 AMFR ITCH ZSWIM5 POTEF UBXN8 POLRMT FBXO11 VIRMA PRKAG3 GTF2F2 PRKN POLG2 | 6.74e-04 | 963 | 238 | 23 | GO:1990234 |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 1.23e-03 | 19 | 238 | 3 | GO:0098871 | |
| GeneOntologyCellularComponent | lamellipodium | 1.33e-03 | 230 | 238 | 9 | GO:0030027 | |
| GeneOntologyCellularComponent | blood microparticle | 1.33e-03 | 144 | 238 | 7 | GO:0072562 | |
| GeneOntologyCellularComponent | focal adhesion | ACTB RPS11 ACTC1 ACTG1 KEAP1 CORO2B PI4KA TLN2 CASK LIMK1 ADGRE5 IL1RL1 PCBP2 | 1.40e-03 | 431 | 238 | 13 | GO:0005925 |
| GeneOntologyCellularComponent | extracellular matrix | LRRC3C ACTA2 LRIG2 SFTPA2 HMCN2 SFTPA1 MMP1 DMBT1 SFTPB WNT7A MMP23B ADAMTS13 FREM3 CASK CLEC14A CTSG AGRN | 1.45e-03 | 656 | 238 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LRRC3C ACTA2 LRIG2 SFTPA2 HMCN2 SFTPA1 MMP1 DMBT1 SFTPB WNT7A MMP23B ADAMTS13 FREM3 CASK CLEC14A CTSG AGRN | 1.50e-03 | 658 | 238 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | lamellar body | 1.67e-03 | 21 | 238 | 3 | GO:0042599 | |
| GeneOntologyCellularComponent | cell division site | 2.20e-03 | 80 | 238 | 5 | GO:0032153 | |
| GeneOntologyCellularComponent | dense body | 2.61e-03 | 7 | 238 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | axon terminus | 2.88e-03 | 210 | 238 | 8 | GO:0043679 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 3.12e-03 | 26 | 238 | 3 | GO:0099571 | |
| GeneOntologyCellularComponent | Derlin-1 retrotranslocation complex | 3.45e-03 | 8 | 238 | 2 | GO:0036513 | |
| GeneOntologyCellularComponent | manchette | 3.87e-03 | 28 | 238 | 3 | GO:0002177 | |
| GeneOntologyCellularComponent | myosin II complex | 3.87e-03 | 28 | 238 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | anchoring junction | EPPK1 PECAM1 ACTB RPS11 ACTC1 ACTG1 FGFRL1 KEAP1 KIRREL2 CORO2B PI4KA TLN2 FRMPD2 MXRA8 GRIA1 CDC42BPB CASK LIMK1 ADGRE5 IL1RL1 PCBP2 | 4.00e-03 | 976 | 238 | 21 | GO:0070161 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 4.14e-03 | 223 | 238 | 8 | GO:0098862 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH10 MYH11 EPPK1 ACTBL2 PECAM1 ACTA1 SARM1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP KEAP1 POTEE MYPN SCO1 ALDOA KIF22 DYNC2H1 POTEF DNAJA3 MYH14 DNAH11 | 4.29e-03 | 1179 | 238 | 24 | GO:0099512 |
| Domain | Actin_CS | 6.15e-14 | 16 | 231 | 9 | IPR004001 | |
| Domain | ACTINS_2 | 1.29e-13 | 17 | 231 | 9 | PS00432 | |
| Domain | Actin/actin-like_CS | 2.56e-13 | 18 | 231 | 9 | IPR020902 | |
| Domain | ACTINS_1 | 3.20e-13 | 8 | 231 | 7 | PS00406 | |
| Domain | ACTINS_ACT_LIKE | 4.81e-13 | 19 | 231 | 9 | PS01132 | |
| Domain | Actin | 9.22e-11 | 31 | 231 | 9 | IPR004000 | |
| Domain | Actin | 9.22e-11 | 31 | 231 | 9 | PF00022 | |
| Domain | ACTIN | 9.22e-11 | 31 | 231 | 9 | SM00268 | |
| Domain | Wnt7 | 1.52e-04 | 2 | 231 | 2 | IPR013300 | |
| Domain | Ig-like_fold | TSPOAP1 PECAM1 FGFRL1 KIRREL2 LRIG2 HMCN2 MYPN PKHD1 RIMBP3C PLXNB1 PLXNA3 MXRA8 MMP23B NRG2 TRIM71 LRRC4C ADGRA2 RIMBP3 IL1RL1 RIMBP3B SEMA3E | 1.92e-04 | 706 | 231 | 21 | IPR013783 |
| Domain | - | TSPOAP1 PECAM1 FGFRL1 KIRREL2 LRIG2 MYPN PKHD1 RIMBP3C PLXNB1 PLXNA3 MXRA8 MMP23B NRG2 TRIM71 LRRC4C ADGRA2 RIMBP3 IL1RL1 RIMBP3B SEMA3E | 2.28e-04 | 663 | 231 | 20 | 2.60.40.10 |
| Domain | P-loop_NTPase | MYH10 MYH11 TDRD9 CMPK2 MCM6 SEPTIN6 DDX5 DDX46 STARD9 AK5 GNL1 PIF1 VCP KIF22 DNHD1 DDX17 DYNC2H1 RNF213 CASK SBNO1 MYH14 CARD11 DNAH11 | 3.59e-04 | 848 | 231 | 23 | IPR027417 |
| Domain | Single_hybrid_motif | 3.78e-04 | 12 | 231 | 3 | IPR011053 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 3.71e-06 | 20 | 175 | 5 | M18415 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 9.77e-06 | 24 | 175 | 5 | M2243 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 1.38e-05 | 64 | 175 | 7 | M7923 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 2.36e-05 | 47 | 175 | 6 | M39829 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 7.69e-05 | 19 | 175 | 4 | M27493 | |
| Pathway | REACTOME_DEFECTIVE_CSF2RB_CAUSES_SMDP5 | 1.01e-04 | 8 | 175 | 3 | M27575 | |
| Pathway | REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION | 1.01e-04 | 8 | 175 | 3 | M26991 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.16e-04 | 21 | 175 | 4 | M27494 | |
| Pathway | WP_FERROPTOSIS | 1.39e-04 | 64 | 175 | 6 | M39768 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 1.45e-04 | 41 | 175 | 5 | M39655 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 1.50e-04 | 9 | 175 | 3 | M47725 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 1.69e-04 | 23 | 175 | 4 | MM15279 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.69e-04 | 23 | 175 | 4 | MM15222 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM | 2.12e-04 | 10 | 175 | 3 | M27573 | |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | MYH10 MYH11 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 POTEKP DDX5 POTEE FASN ALDOA VCP DDX17 IPO7 POTEF AGPAT1 MYH14 TKT PCBP2 | 1.84e-14 | 288 | 241 | 20 | 31501420 |
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 1.04e-13 | 6 | 241 | 6 | 22989508 | |
| Pubmed | 1.04e-13 | 6 | 241 | 6 | 12009869 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 1.04e-13 | 6 | 241 | 6 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 1.04e-13 | 6 | 241 | 6 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 1.04e-13 | 6 | 241 | 6 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 1.04e-13 | 6 | 241 | 6 | 8661406 | |
| Pubmed | 1.04e-13 | 6 | 241 | 6 | 23017337 | ||
| Pubmed | 1.04e-13 | 6 | 241 | 6 | 9841925 | ||
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 1.04e-13 | 6 | 241 | 6 | 9971772 | |
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 1.04e-13 | 6 | 241 | 6 | 10074138 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 1.04e-13 | 6 | 241 | 6 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 1.04e-13 | 6 | 241 | 6 | 11709093 | |
| Pubmed | 1.04e-13 | 6 | 241 | 6 | 10049817 | ||
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 1.04e-13 | 6 | 241 | 6 | 23875777 | |
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 2.27e-13 | 11 | 241 | 7 | 23294842 | |
| Pubmed | 5.41e-13 | 12 | 241 | 7 | 23071112 | ||
| Pubmed | 7.24e-13 | 7 | 241 | 6 | 22535526 | ||
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 7.24e-13 | 7 | 241 | 6 | 17504171 | |
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 7.24e-13 | 7 | 241 | 6 | 18443296 | |
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 7.24e-13 | 7 | 241 | 6 | 22640593 | |
| Pubmed | 7.24e-13 | 7 | 241 | 6 | 22465675 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | ACACB ACTB ACTC1 ACTG1 MCM6 DDX5 FASN DDX46 MKI67 ALDOA GCN1 CAD DDX17 IPO7 TDP2 TRIM33 SBNO1 TKT PCBP1 PCBP2 | 1.01e-12 | 357 | 241 | 20 | 37059091 |
| Pubmed | 2.32e-12 | 14 | 241 | 7 | 21923909 | ||
| Pubmed | 2.88e-12 | 8 | 241 | 6 | 20147394 | ||
| Pubmed | 2.88e-12 | 8 | 241 | 6 | 23260110 | ||
| Pubmed | 2.88e-12 | 8 | 241 | 6 | 14694110 | ||
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 4.32e-12 | 15 | 241 | 7 | 16824795 | |
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 8.59e-12 | 9 | 241 | 6 | 10556093 | |
| Pubmed | Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. | 8.59e-12 | 9 | 241 | 6 | 8892894 | |
| Pubmed | 8.59e-12 | 9 | 241 | 6 | 18775311 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP DDX5 POTEE SCML2 DDX46 MKI67 GCN1 POTEF GTF2F2 PCBP1 | 9.03e-12 | 271 | 241 | 17 | 32433965 |
| Pubmed | 2.13e-11 | 10 | 241 | 6 | 1907279 | ||
| Pubmed | Non-viral cellular substrates for human immunodeficiency virus type 1 protease. | 2.13e-11 | 10 | 241 | 6 | 1991513 | |
| Pubmed | 2.13e-11 | 10 | 241 | 6 | 23575248 | ||
| Pubmed | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 MCM6 FASN ALDOA VCP GRIA1 PKN1 PCBP1 PCBP2 HERC4 | 2.32e-11 | 247 | 241 | 16 | 30713523 | |
| Pubmed | 4.67e-11 | 11 | 241 | 6 | 30962377 | ||
| Pubmed | Quantitative proteomic analysis of lentiviral vectors using 2-DE. | 4.67e-11 | 11 | 241 | 6 | 19639585 | |
| Pubmed | EPPK1 ACTBL2 ACTA1 ACTA2 RPS11 ACTC1 ACTG1 ACTG2 MCM6 DDX5 FASN MYPN GLRX MKI67 SNU13 SCFD1 ALDOA GCN1 VCP CAD DDX17 IPO7 RNF213 MYH14 TKT PCBP1 PCBP2 | 5.11e-11 | 844 | 241 | 27 | 25963833 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYH10 MYH11 EPPK1 ACTA1 ACTA2 ACTB RPS11 ACTC1 ACTG1 ACTG2 MCM6 DDX5 FASN DDX46 MKI67 BOP1 DMBT1 ALDOA VCP KIF22 CAD PCBP3 DDX17 IPO7 MYH14 TKT PCBP1 PCBP2 | 1.39e-10 | 949 | 241 | 28 | 36574265 |
| Pubmed | MYH10 MYH11 ACTB ACTG1 POTEKP FASN PKHD1 GCN1 CAD DDX17 POTEF CDC42BPB VIRMA MYH14 | 1.73e-10 | 202 | 241 | 14 | 24639526 | |
| Pubmed | 2.98e-10 | 14 | 241 | 6 | 17411366 | ||
| Pubmed | 3.01e-10 | 40 | 241 | 8 | 32317081 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | MYH10 ACTG1 PFAS MCM6 TRRAP DDX5 FASN ALDOA GMPPB GCN1 PLD4 DDX17 IPO7 MYOF TKT PCBP1 PCBP2 | 3.72e-10 | 344 | 241 | 17 | 30333137 |
| Pubmed | MYH10 ACTA1 ACTB RPS11 MCM6 FASN SNU13 ALDOA GCN1 VCP CAD DDX17 IPO7 CBS MYOF TKT PCBP1 PCBP2 | 4.45e-10 | 397 | 241 | 18 | 21319273 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | MYH10 ACTBL2 ACTB ACTC1 ACTG1 FASN ALDOA GCN1 VCP CAD DDX17 RNF213 MYOF TKT PCBP1 | 7.57e-10 | 268 | 241 | 15 | 33024031 |
| Pubmed | 1.21e-09 | 17 | 241 | 6 | 23408915 | ||
| Pubmed | 1.21e-09 | 17 | 241 | 6 | 17360745 | ||
| Pubmed | 1.21e-09 | 17 | 241 | 6 | 8997639 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYH10 ATP8B4 RPS11 ACTG1 PFAS MCM6 NDUFS2 DDX5 FASN NOP9 STARD9 PI4KA MKI67 DLAT SNU13 TLN2 BOP1 SCFD1 ALDOA GCN1 DNHD1 CAD DDX17 IPO7 DYNC2H1 POLRMT CBS SLC5A2 DNAJA3 SBNO1 MYH14 TKT PCBP1 | 1.41e-09 | 1425 | 241 | 33 | 30948266 |
| Pubmed | MYH10 ACTB RPS11 ACTC1 DDX5 FASN DDX46 MKI67 BOP1 ALDOA GCN1 DDX17 CFAP36 TKT PCBP1 PCBP2 | 1.63e-09 | 330 | 241 | 16 | 32529326 | |
| Pubmed | EFCAB5 MYH10 MYH11 ACACB ACTBL2 ACTA1 ACTA2 ACTB RPS11 GATB ACTC1 ACTG1 ACTG2 DDX5 POTEE FASN ACSM3 STARD9 PKHD1 DLAT SNU13 PLXNA3 DDX17 ZSWIM5 POTEF UBXN8 GRIA1 RNF17 SBNO1 MYH14 TKT MARF1 TENM1 | 1.89e-09 | 1442 | 241 | 33 | 35575683 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | MYH10 MYH11 ACTB FASN PI4KA CRYBG1 GCN1 CAD DDX17 IPO7 CDC42BPB MYOF MYH14 | 1.95e-09 | 202 | 241 | 13 | 33005030 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYH10 EPPK1 ACTBL2 ACTA2 ACTB RPS11 ACTC1 PFAS MCM6 DDX5 FASN DDX46 DLAT SNU13 SCFD1 ALDOA GCN1 VCP CAD PCBP3 DDX17 IPO7 GSS DNAJA3 PREP TKT PANK4 PCBP1 PCBP2 | 2.30e-09 | 1149 | 241 | 29 | 35446349 |
| Pubmed | 3.72e-09 | 20 | 241 | 6 | 21129374 | ||
| Pubmed | 3.74e-09 | 54 | 241 | 8 | 22266860 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPPK1 TMC6 APBB3 FGFRL1 PFAS TMCO6 SFI1 ZZEF1 TRRAP FASN PI4KA CASKIN1 TLN2 GCN1 PLXNA3 SH3RF1 WNT7B AOC2 POLRMT ADGRA2 CDC42BPB MYOF PWWP2B CTDP1 LRP3 PKN1 LTK AGRN | 4.07e-09 | 1105 | 241 | 28 | 35748872 |
| Pubmed | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP POTEE STARD9 MMP1 CAD DDX17 POTEF LPL TENM1 PCBP1 PCBP2 CAPN15 | 4.08e-09 | 513 | 241 | 19 | 25798074 | |
| Pubmed | 5.17e-09 | 21 | 241 | 6 | 23526992 | ||
| Pubmed | 6.06e-09 | 37 | 241 | 7 | 22001906 | ||
| Pubmed | 7.07e-09 | 22 | 241 | 6 | 21408140 | ||
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 7.07e-09 | 22 | 241 | 6 | 16526095 | |
| Pubmed | The Fgf9-Nolz1-Wnt2 axis regulates morphogenesis of the lung. | 7.39e-09 | 38 | 241 | 7 | 37497597 | |
| Pubmed | ACTA1 ACTB TRRAP DDX5 FASN MKI67 DMBT1 GCN1 CAD DDX17 MYOF MARF1 PCBP1 PCBP2 | 8.22e-09 | 272 | 241 | 14 | 31010829 | |
| Pubmed | ACTBL2 ACTB ACTC1 POTEE DMBT1 ZSWIM5 POTEF LRRC4C FREM3 CEP164 PRKAG3 | 8.38e-09 | 149 | 241 | 11 | 22664934 | |
| Pubmed | MRS2 ACTA1 ACTC1 SLC38A5 KEAP1 DDX46 DLAT VCP AMFR CFAP36 RNF213 CHCHD6 TDP2 ARMC1 PCBP2 HERC4 AGRN CAPN15 | 9.04e-09 | 481 | 241 | 18 | 28190767 | |
| Pubmed | Essential and supporting host cell factors for HIV-1 budding. | 9.51e-09 | 23 | 241 | 6 | 22004035 | |
| Pubmed | MYH11 ACTBL2 ACTA1 ACTA2 ACTB RPS11 ACTC1 ACTG1 ACTG2 TMCO6 POTEKP DDX5 POTEE FASN DDX46 SNU13 SCFD1 HEATR5B ALDOA VCP CAD PCBP3 DDX17 POTEF POLRMT MYH14 PCBP1 PCBP2 | 1.02e-08 | 1153 | 241 | 28 | 29845934 | |
| Pubmed | MYH10 MYH11 ACTA1 ACTB ACTC1 FASN ALDOA VCP ITCH CDC42BPB MYH14 TKT | 1.08e-08 | 191 | 241 | 12 | 33762435 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 1.12e-08 | 5 | 241 | 4 | 17855024 | |
| Pubmed | MYH10 ACTB RPS11 MCM6 SEPTIN6 DDX5 FASN CASKIN1 MKI67 DLAT SNU13 ALDOA GCN1 VCP CAD DDX17 WNT7B MYOF MYH14 TKT PCBP1 PCBP2 AGRN | 1.18e-08 | 803 | 241 | 23 | 36517590 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPPK1 ACTBL2 ACTA1 RPS11 ACTC1 ACTG1 MCM6 TRRAP F5 DDX5 FASN NOP9 DDX46 PI4KA MKI67 BOP1 HEATR5B GCN1 VCP KIF22 CAD DDX17 IPO7 MYH14 PCBP1 PCBP2 | 1.46e-08 | 1024 | 241 | 26 | 24711643 |
| Pubmed | ACTB ACTG1 MCM6 TRRAP DDX5 DDX46 SNU13 GCN1 TBPL2 UBR2 PCBP3 DDX17 GTF2F2 CTDP1 PCBP1 PCBP2 | 1.74e-08 | 390 | 241 | 16 | 17643375 | |
| Pubmed | MYH10 ACTB RPS11 DDX5 FASN DDX46 GCN1 VCP CAD DDX17 MYH14 PCBP1 PCBP2 | 1.88e-08 | 244 | 241 | 13 | 28902428 | |
| Pubmed | 1.89e-08 | 13 | 241 | 5 | 24785085 | ||
| Pubmed | 1.89e-08 | 13 | 241 | 5 | 19835856 | ||
| Pubmed | 2.13e-08 | 26 | 241 | 6 | 24742657 | ||
| Pubmed | Hippo-Foxa2 signaling pathway plays a role in peripheral lung maturation and surfactant homeostasis. | 2.17e-08 | 44 | 241 | 7 | 23620511 | |
| Pubmed | MYH10 MYH11 ACTBL2 ACTA1 ACTB RPS11 ACTG1 NDUFS2 SEPTIN6 DDX5 FASN CORO2B PI4KA CASKIN1 FBXO41 DLAT TLN2 ALDOA VCP CAD DDX17 WDR7 GRIA1 CDC42BPB VIRMA CASK PITPNM1 MYH14 TKT PCBP1 DNAH11 | 2.17e-08 | 1431 | 241 | 31 | 37142655 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH10 ACTB RPS11 PFAS MCM6 TRRAP DDX5 FASN PI4KA MKI67 DLAT BOP1 SCFD1 ALDOA GMPPB GCN1 VCP MPO CAD CCDC22 ITCH DDX17 IPO7 POLRMT CHCHD6 DNAJA3 MYH14 TKT PCBP1 AGRN | 2.24e-08 | 1353 | 241 | 30 | 29467282 |
| Pubmed | 2.44e-08 | 96 | 241 | 9 | 23580065 | ||
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | MYH10 MYH11 EPPK1 ACTBL2 ACTB RPS11 ACTC1 DDX5 POTEE FASN ALDOA CAD DDX17 POTEF CDC42BPB MYH14 TKT PCBP1 PCBP2 | 2.90e-08 | 580 | 241 | 19 | 35676659 |
| Pubmed | beta-Catenin is required for specification of proximal/distal cell fate during lung morphogenesis. | 2.92e-08 | 14 | 241 | 5 | 12885771 | |
| Pubmed | 2.92e-08 | 14 | 241 | 5 | 11493558 | ||
| Pubmed | 2.92e-08 | 14 | 241 | 5 | 23696835 | ||
| Pubmed | Surfactant lipid synthesis and lamellar body formation in glycogen-laden type II cells. | 3.34e-08 | 6 | 241 | 4 | 15169678 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | MYH10 MYH11 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP POTEE FASN ALAD ALDOA VCP MPO PCBP3 ITCH POTEF MXRA8 GSS MYOF TKT PCBP1 PCBP2 CTSG AGRN | 3.51e-08 | 1070 | 241 | 26 | 23533145 |
| Pubmed | HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis. | 3.91e-08 | 135 | 241 | 10 | 23874603 | |
| Pubmed | 4.35e-08 | 15 | 241 | 5 | 23405202 | ||
| Pubmed | MYH10 ACTBL2 ACTB ACTC1 ACTG1 F5 DDX5 POTEE DDX46 PI4KA MKI67 SNU13 VCP KIF22 CAD PCBP3 DDX17 CASK MYOF PCBP2 | 4.45e-08 | 660 | 241 | 20 | 32780723 | |
| Pubmed | PI4K2B ACTB RPS11 ACTC1 ACTG1 F5 DDX5 FASN PI4KA MKI67 HEATR5B ALDOA GCN1 AMFR CAD ITCH DDX17 SLC11A2 IPO7 AGPAT1 RNF213 MYH14 PREP MARF1 ADGRE5 PCBP1 PCBP2 | 5.20e-08 | 1168 | 241 | 27 | 19946888 | |
| Pubmed | MYH10 ACTA1 ACTB RPS11 DDX5 FASN DLAT SCFD1 ALDOA VCP CAD DDX17 IPO7 CASK DNAJA3 PCBP1 PCBP2 | 5.90e-08 | 484 | 241 | 17 | 31995728 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MYH10 EPPK1 ACTBL2 ACTA1 ACTB RPS11 ACTG1 PFAS MCM6 NDUFS2 DDX5 FASN DDX46 SCO1 DLAT SNU13 ALDOA GCN1 GNL1 VCP CAD DDX17 IPO7 CBS DNAJA3 GTF2F2 SBNO1 TKT PCBP1 PCBP2 | 5.99e-08 | 1415 | 241 | 30 | 28515276 |
| Pubmed | EFCAB5 MYH10 ACTA1 ACTB RPS11 ACTG1 KEAP1 DDX5 FASN DLAT ALDOA GCN1 VCP CAD DDX17 IPO7 POLRMT CDC42BPB CBS CASK PCBP1 PCBP2 | 6.17e-08 | 809 | 241 | 22 | 32129710 | |
| Pubmed | Wnt7b regulates mesenchymal proliferation and vascular development in the lung. | 7.74e-08 | 7 | 241 | 4 | 12361974 | |
| Pubmed | EFCAB5 CNNM2 ACTBL2 ACTA1 ACTB RPS11 ACTG1 SEPTIN6 DDX5 ZSWIM9 FASN ALDOA CAD TRIM33 PCBP1 | 8.66e-08 | 382 | 241 | 15 | 37249651 | |
| Pubmed | 8.86e-08 | 17 | 241 | 5 | 17560563 | ||
| Pubmed | 8.86e-08 | 17 | 241 | 5 | 21385574 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | MYH10 LYPLAL1 ACTBL2 ACTA1 ACTB RPS11 ACTG1 DDX5 FASN MKI67 SNU13 ALDOA VCP CAD DDX17 POLRMT MYH14 PCBP1 PCBP2 | 9.55e-08 | 626 | 241 | 19 | 33644029 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | MYH10 EPPK1 ACTA2 ACTB ACTC1 ACTG1 PI4KA ALDOA GCN1 KLHL4 AMFR CAD PCBP3 IPO7 ZSWIM5 PITPNM1 DNAJA3 PCBP1 | 1.00e-07 | 564 | 241 | 18 | 21565611 |
| Interaction | ACTG2 interactions | 1.72e-10 | 49 | 230 | 10 | int:ACTG2 | |
| Interaction | ERRFI1 interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP POTEE POTEF DCTN6 LTK | 3.50e-09 | 107 | 230 | 12 | int:ERRFI1 |
| Interaction | TFCP2 interactions | MYH10 MYH11 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 POTEKP DDX5 POTEE FASN ALDOA VCP DDX17 IPO7 POTEF AGPAT1 PITPNM1 MYH14 FARS2 TKT PCBP2 | 6.39e-09 | 436 | 230 | 22 | int:TFCP2 |
| Interaction | MCM2 interactions | EPPK1 ACTBL2 ACTA1 ACTA2 RPS11 ACTC1 ACTG1 ACTG2 MCM6 KEAP1 TRRAP TERF2IP DDX5 CDAN1 FASN MYPN GLRX MKI67 SNU13 SCFD1 ALDOA GCN1 VCP CAD DDX17 IPO7 MCPH1 RNF213 VIRMA TRIM33 SBNO1 MYH14 TKT PRKN PCBP1 PCBP2 | 7.00e-09 | 1081 | 230 | 36 | int:MCM2 |
| Interaction | SLX4 interactions | ACACB ACTB ACTC1 ACTG1 MCM6 KEAP1 TERF2IP DDX5 FASN DDX46 MKI67 ALDOA GCN1 VCP CAD DDX17 IPO7 VIRMA TDP2 TRIM33 GTF2F2 SBNO1 TKT PCBP1 PCBP2 | 1.02e-08 | 572 | 230 | 25 | int:SLX4 |
| Interaction | GC interactions | 3.37e-08 | 62 | 230 | 9 | int:GC | |
| Interaction | WASH8P interactions | 8.10e-08 | 11 | 230 | 5 | int:WASH8P | |
| Interaction | POTEJ interactions | 1.24e-07 | 52 | 230 | 8 | int:POTEJ | |
| Interaction | HDAC6 interactions | MYH10 MYH11 EPPK1 ACTBL2 ACTB RPS11 ACTC1 ACTG1 TRRAP DDX5 POTEE FASN DLAT ALDOA VCP CAD ITCH DDX17 IPO7 POTEF FBXO11 CDC42BPB VIRMA BBS10 TRIM33 MYH14 TKT PRKN PCBP1 PCBP2 | 2.81e-07 | 929 | 230 | 30 | int:HDAC6 |
| Interaction | LGR4 interactions | MYH10 MYH11 ACTB ACTG1 POTEKP FASN PKHD1 GCN1 CAD DDX17 POTEF POLRMT CDC42BPB VIRMA MYH14 | 3.65e-07 | 262 | 230 | 15 | int:LGR4 |
| Interaction | NBR1 interactions | EPPK1 LYPLAL1 ACTG1 KEAP1 TRRAP DDX5 FASN GLRX MKI67 VCP CAD DDX17 IPO7 VIRMA MYOF PREP LPL PCBP1 | 4.09e-07 | 380 | 230 | 18 | int:NBR1 |
| Interaction | NAA80 interactions | 5.07e-07 | 15 | 230 | 5 | int:NAA80 | |
| Interaction | DNASE1 interactions | 5.63e-07 | 7 | 230 | 4 | int:DNASE1 | |
| Interaction | NPHP4 interactions | MYH10 EPPK1 ACTA2 ACTB ACTC1 ACTG1 PI4KA KLHL4 AMFR PCBP3 ZSWIM5 CEP164 PITPNM1 PRKN | 5.89e-07 | 236 | 230 | 14 | int:NPHP4 |
| Interaction | LRRC31 interactions | MYH10 MYH11 ACTB FASN PI4KA CRYBG1 GCN1 CAD DDX17 IPO7 CDC42BPB MYOF MYH14 | 7.08e-07 | 205 | 230 | 13 | int:LRRC31 |
| Interaction | PHACTR2 interactions | 7.89e-07 | 29 | 230 | 6 | int:PHACTR2 | |
| Interaction | CAP2 interactions | 8.28e-07 | 66 | 230 | 8 | int:CAP2 | |
| Interaction | YAP1 interactions | MYH10 MYH11 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 POTEKP TRRAP DDX5 POTEE FASN SCML2 DDX46 DLAT ALDOA GCN1 VCP CAD CCDC22 ITCH DDX17 IPO7 POTEF AGPAT1 GTF2F2 MYH14 TKT PRKN PCBP1 PCBP2 | 9.81e-07 | 1095 | 230 | 32 | int:YAP1 |
| Interaction | LRRC20 interactions | 1.89e-06 | 19 | 230 | 5 | int:LRRC20 | |
| Interaction | AAR2 interactions | EPPK1 ACTBL2 ACTA1 ACTB RPS11 ACTG1 PFAS DDX5 FASN DDX46 ALDOA GCN1 VCP CAD DDX17 IPO7 POTEF VIRMA CBS TKT PRKN PCBP1 PCBP2 | 2.01e-06 | 657 | 230 | 23 | int:AAR2 |
| Interaction | TWF2 interactions | 2.17e-06 | 100 | 230 | 9 | int:TWF2 | |
| Interaction | POTEF interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP SFTPA2 POTEF VIRMA TKT ADGRE5 | 2.33e-06 | 228 | 230 | 13 | int:POTEF |
| Interaction | ABRA interactions | 3.03e-06 | 36 | 230 | 6 | int:ABRA | |
| Interaction | POTEI interactions | 3.26e-06 | 105 | 230 | 9 | int:POTEI | |
| Interaction | POTEE interactions | 3.27e-06 | 134 | 230 | 10 | int:POTEE | |
| Interaction | PFN3 interactions | 3.29e-06 | 10 | 230 | 4 | int:PFN3 | |
| Interaction | TMSB4X interactions | 3.64e-06 | 80 | 230 | 8 | int:TMSB4X | |
| Interaction | COTL1 interactions | 4.22e-06 | 58 | 230 | 7 | int:COTL1 | |
| Interaction | SCIN interactions | 4.22e-06 | 58 | 230 | 7 | int:SCIN | |
| Interaction | ISG15 interactions | MYH10 EPPK1 ACTBL2 ACTA1 ACTB ACTC1 ACTG1 FASN ALDOA GCN1 VCP CAD DDX17 RNF213 MYOF FARS2 TKT PCBP1 HERC4 | 4.30e-06 | 494 | 230 | 19 | int:ISG15 |
| Interaction | TRIM21 interactions | EFCAB5 CNNM2 ACTBL2 ACTA1 ACTA2 ACTB RPS11 ACTG1 TRRAP SEPTIN6 DDX5 ZSWIM9 FASN PAN2 ALDOA VCP CAD VIRMA TRIM33 TKT PRKN PCBP1 AGRN | 4.43e-06 | 689 | 230 | 23 | int:TRIM21 |
| Interaction | FGD5 interactions | MYH10 MYH11 ACTA1 ACTB ACTC1 TRRAP FASN ALDOA VCP CDC42BPB MYH14 TKT | 4.84e-06 | 207 | 230 | 12 | int:FGD5 |
| Interaction | NDN interactions | MYH10 ACTB RPS11 ACTC1 RCBTB2 DDX5 FASN DDX46 MKI67 BOP1 ALDOA GCN1 DDX17 CFAP36 TDP2 TKT PCBP1 PCBP2 | 4.95e-06 | 453 | 230 | 18 | int:NDN |
| Interaction | PXK interactions | 6.67e-06 | 41 | 230 | 6 | int:PXK | |
| Interaction | KIF23 interactions | MYH10 MYH11 EPPK1 MRS2 ACTA1 RPS11 ACTC1 POTEKP TERF2IP DDX5 POTEE FASN MKI67 DLAT SNU13 BOP1 HEATR5B GCN1 PCBP3 DDX17 IPO7 CHCHD6 VIRMA CBS LIMK1 MYH14 PRKN PCBP1 PCBP2 | 6.96e-06 | 1031 | 230 | 29 | int:KIF23 |
| Interaction | HSF1 interactions | ACTA1 ACTB PFAS MCM6 TRRAP NDUFS2 DDX5 FASN SCO1 ALDOA VCP MPO CAD DDX17 IPO7 AGPAT1 RNF17 CBS TRIM33 MYOF PCBP1 | 7.21e-06 | 609 | 230 | 21 | int:HSF1 |
| Interaction | DSTN interactions | MYH11 LYPLAL1 ACTA1 ACTA2 ACTB ACTG1 VCP VIRMA TKT PRKN PCBP1 | 1.05e-05 | 187 | 230 | 11 | int:DSTN |
| Interaction | CHMP4B interactions | MYH10 MYH11 EPPK1 METRNL RPS11 ACTC1 POTEKP DDX5 POTEE FASN DDX46 MKI67 SNU13 TLN2 GCN1 VCP PCBP3 DDX17 IPO7 MYH14 CTDP1 PCBP1 PCBP2 | 1.06e-05 | 727 | 230 | 23 | int:CHMP4B |
| Interaction | NEK4 interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP POTEE STARD9 MMP1 CAD DDX17 POTEF VIRMA LPL TENM1 PCBP1 PCBP2 CAPN15 | 1.26e-05 | 582 | 230 | 20 | int:NEK4 |
| Interaction | CDK9 interactions | MYH10 ACTBL2 ACTB RPS11 ACTC1 ACTG1 TRRAP TERF2IP DDX5 FASN SNU13 CAD DDX17 SYDE1 GSS CASK TRIM33 MYH14 CTDP1 PRKN PCBP1 PCBP2 | 1.32e-05 | 685 | 230 | 22 | int:CDK9 |
| Interaction | CHMP4C interactions | MYH10 MYH11 RPS11 SLITRK1 DDX5 FASN STARD9 MKI67 SNU13 BOP1 ALDOA VCP CAD DDX17 IPO7 AGPAT1 RNF213 DNAJA3 MYOF TKT CTDP1 PCBP2 | 1.38e-05 | 687 | 230 | 22 | int:CHMP4C |
| Interaction | AIMP2 interactions | ACTB ACTC1 ACTG1 PFAS TERF2IP DDX5 FASN ALDOA VCP CAD DDX17 IPO7 VIRMA CBS PRKN PCBP1 PCBP2 | 1.56e-05 | 446 | 230 | 17 | int:AIMP2 |
| Interaction | SPDL1 interactions | MYH10 MYH11 EPPK1 ACTBL2 ACTB ACTC1 TRRAP POTEE FASN DDX46 CAD MYH14 PRKN PCBP2 | 1.68e-05 | 315 | 230 | 14 | int:SPDL1 |
| Interaction | MYOC interactions | 1.70e-05 | 48 | 230 | 6 | int:MYOC | |
| Interaction | RNF17 interactions | 2.04e-05 | 15 | 230 | 4 | int:RNF17 | |
| Interaction | FBXO40 interactions | 2.04e-05 | 15 | 230 | 4 | int:FBXO40 | |
| Interaction | AURKB interactions | MYH10 MYH11 EPPK1 RPS11 ACTC1 POTEKP ZZEF1 TRRAP DDX5 FASN DDX46 SFTPA2 MKI67 SCO1 BOP1 GCN1 VCP DDX17 RNF213 MYH14 CTDP1 PRKN PCBP1 | 2.19e-05 | 761 | 230 | 23 | int:AURKB |
| Interaction | TNIP1 interactions | MYH10 MYH11 EPPK1 ACTA1 ACTA2 ACTB RPS11 ACTC1 ACTG1 ACTG2 MCM6 DDX5 FASN DDX46 MKI67 BOP1 SCFD1 DMBT1 ALDOA VCP KIF22 CAD PCBP3 DDX17 IPO7 POTEF MYH14 TKT CARD11 PCBP1 PCBP2 | 2.32e-05 | 1217 | 230 | 31 | int:TNIP1 |
| Interaction | ACP1 interactions | 2.56e-05 | 104 | 230 | 8 | int:ACP1 | |
| Interaction | ASXL1 interactions | ACTG1 FASN SNU13 GCN1 VCP CAD DDX17 IPO7 VIRMA CBS DNAJA3 PCBP1 PCBP2 | 2.67e-05 | 286 | 230 | 13 | int:ASXL1 |
| Interaction | NASP interactions | MYH10 ACTC1 MCM6 TRRAP TERF2IP CDAN1 FASN SCO1 VCP TRIM33 PRKN | 2.72e-05 | 207 | 230 | 11 | int:NASP |
| Interaction | CAP1 interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 MCM6 FASN VCP VIRMA PRKN | 2.72e-05 | 207 | 230 | 11 | int:CAP1 |
| Interaction | GRIK2 interactions | 2.90e-05 | 32 | 230 | 5 | int:GRIK2 | |
| Interaction | COBL interactions | 3.06e-05 | 78 | 230 | 7 | int:COBL | |
| Interaction | PRKCE interactions | 3.09e-05 | 173 | 230 | 10 | int:PRKCE | |
| Interaction | PTMA interactions | MYH10 ACTA2 ACTB ACTC1 ACTG1 KEAP1 TERF2IP SEPTIN6 MKI67 PAN2 AGRN | 3.38e-05 | 212 | 230 | 11 | int:PTMA |
| Interaction | REG3A interactions | 3.50e-05 | 17 | 230 | 4 | int:REG3A | |
| Interaction | PPP1R9B interactions | MYH10 MYH11 ACTA1 ACTA2 ACTB RPS11 ACTC1 ACTG1 NDUFS2 SEPTIN6 DDX5 FASN CORO2B FBXO41 DLAT ALDOA VCP WDR7 PCBP1 PCBP2 | 3.56e-05 | 626 | 230 | 20 | int:PPP1R9B |
| Interaction | LINC01554 interactions | 3.77e-05 | 142 | 230 | 9 | int:LINC01554 | |
| Interaction | CFL1 interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 PAN2 ALDOA VCP VIRMA LIMK1 TKT PRKN PCBP1 | 3.77e-05 | 384 | 230 | 15 | int:CFL1 |
| Interaction | MRTFB interactions | 4.62e-05 | 57 | 230 | 6 | int:MRTFB | |
| Interaction | EIF2D interactions | 4.62e-05 | 57 | 230 | 6 | int:EIF2D | |
| Interaction | WDR1 interactions | ACTB ACTC1 ACTG1 KEAP1 POTEE SCFD1 GMPPB VCP TKT PRKN CARD11 | 4.74e-05 | 220 | 230 | 11 | int:WDR1 |
| Interaction | HSD11B1L interactions | 4.96e-05 | 7 | 230 | 3 | int:HSD11B1L | |
| Interaction | ADARB1 interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP DDX5 SCML2 DDX46 MKI67 GCN1 POTEF GTF2F2 ADGRE5 PCBP1 | 4.98e-05 | 489 | 230 | 17 | int:ADARB1 |
| Interaction | PRC1 interactions | MYH10 EPPK1 RPS11 ACTC1 MCM6 POTEKP ZZEF1 TRRAP DDX5 FASN DDX46 MKI67 SNU13 BOP1 GCN1 VCP KIF22 PCBP3 DDX17 CHCHD6 VIRMA CASK CTDP1 PRKN PCBP1 PCBP2 | 5.10e-05 | 973 | 230 | 26 | int:PRC1 |
| Interaction | STAG2 interactions | 5.58e-05 | 224 | 230 | 11 | int:STAG2 | |
| Interaction | ERBB3 interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP POTEE SCFD1 ALDOA ITCH POTEF NRG2 | 6.19e-05 | 355 | 230 | 14 | int:ERBB3 |
| Interaction | CCDC8 interactions | EPPK1 RPS11 ACTC1 ACTG1 MCM6 F5 DDX5 FASN NOP9 PI4KA MKI67 HEATR5B GCN1 VCP CAD DDX17 IPO7 MYH14 PRKN PCBP2 | 6.81e-05 | 656 | 230 | 20 | int:CCDC8 |
| Interaction | KIF20A interactions | MYH10 MYH11 EPPK1 RPS11 ACTC1 HMGCR POTEKP TRRAP DDX5 POTEE FASN DDX46 MKI67 PAN2 BOP1 GCN1 VCP PCBP3 DDX17 DYNC2H1 POLRMT CHCHD6 CDC42BPB VIRMA MYH14 CTDP1 PCBP1 | 7.19e-05 | 1052 | 230 | 27 | int:KIF20A |
| Interaction | PPP5C interactions | MYH10 MYH11 ACTB ACTG1 FBXO41 ALDOA VCP BRWD1 CAD CDC42BPB GSS PRKN | 7.25e-05 | 272 | 230 | 12 | int:PPP5C |
| Interaction | ACTR1A interactions | MYH10 ACTA2 ACTB ACTC1 ACTG1 MCM6 SCFD1 VCP CAD VIRMA DCTN6 PRKN | 7.77e-05 | 274 | 230 | 12 | int:ACTR1A |
| Interaction | METTL14 interactions | MYH10 ACTB RPS11 ACTC1 MCM6 DDX5 DDX46 DLAT ALDOA GCN1 VCP DDX17 IPO7 VIRMA TRIM33 MYH14 PCBP1 PCBP2 | 7.82e-05 | 558 | 230 | 18 | int:METTL14 |
| Interaction | SFTPA1 interactions | 7.88e-05 | 8 | 230 | 3 | int:SFTPA1 | |
| Interaction | PDCD6IP interactions | 7.95e-05 | 233 | 230 | 11 | int:PDCD6IP | |
| Interaction | NEXN interactions | 8.26e-05 | 91 | 230 | 7 | int:NEXN | |
| Interaction | ECT2 interactions | MYH10 MYH11 EPPK1 RPS11 ACTC1 MCM6 POTEKP TRRAP TERF2IP DDX5 POTEE FASN DDX46 MKI67 SNU13 PCBP3 DDX17 IPO7 CEP164 MYH14 CTDP1 PRKN PCBP1 PCBP2 | 8.32e-05 | 887 | 230 | 24 | int:ECT2 |
| Interaction | USP48 interactions | MYH10 MYH11 ACTB ACTC1 PFAS NDUFS2 TERF2IP DDX5 CORO2B ACSM3 DLAT ALDOA VCP PCBP3 DDX17 RNF213 MYH14 TKT PCBP1 PCBP2 | 8.72e-05 | 668 | 230 | 20 | int:USP48 |
| Interaction | HTT interactions | MYH10 MYH11 EPPK1 TSPOAP1 ACTBL2 ACTA1 ACTB ACTG1 TRRAP NDUFS2 DDX5 FASN AK5 DLAT ALDOA GNL1 VCP AMFR CAD ITCH IPO7 VIRMA CBS TKT CTDP1 | 8.99e-05 | 949 | 230 | 25 | int:HTT |
| Interaction | BAP1 interactions | MYH10 EPPK1 ACTBL2 ACTA2 ACTB RPS11 ACTC1 PFAS MCM6 KEAP1 TERF2IP DDX5 FASN DDX46 DLAT SNU13 SCFD1 ALDOA GCN1 VCP CAD PCBP3 DDX17 IPO7 GSS DNAJA3 PREP TKT PANK4 PCBP1 PCBP2 | 9.72e-05 | 1314 | 230 | 31 | int:BAP1 |
| Interaction | AKR1B10 interactions | 9.94e-05 | 41 | 230 | 5 | int:AKR1B10 | |
| Interaction | WASHC1 interactions | 1.01e-04 | 94 | 230 | 7 | int:WASHC1 | |
| Interaction | SRCAP interactions | 1.07e-04 | 127 | 230 | 8 | int:SRCAP | |
| Interaction | RHOA interactions | EPPK1 ACTA2 ACTC1 SLC38A5 RIPOR3 DGKH TRRAP NDUFS2 PI4KA MKI67 SCO1 SCFD1 GCN1 PLXNB1 VCP KIF22 CAD ITCH SLC11A2 AGPAT1 POLRMT CDC42BPB VIRMA PITPNM1 MYOF LPL MARF1 ADGRE5 PKN1 | 1.09e-04 | 1199 | 230 | 29 | int:RHOA |
| Interaction | AGO2 interactions | MYH10 ACTB RPS11 TRRAP NDUFS2 DDX5 DDX46 ALDOA ITCH POTEF TRIM71 VIRMA MARF1 PRKN PCBP1 PCBP2 | 1.11e-04 | 472 | 230 | 16 | int:AGO2 |
| Interaction | DUX4L9 interactions | 1.12e-04 | 42 | 230 | 5 | int:DUX4L9 | |
| Interaction | RNF217 interactions | 1.17e-04 | 9 | 230 | 3 | int:RNF217 | |
| Interaction | NUPR1 interactions | MYH10 ACTBL2 ACTB ACTC1 ACTG1 F5 DDX5 POTEE DDX46 PI4KA MKI67 SNU13 VCP KIF22 CAD PCBP3 DDX17 CASK MYOF PCBP2 | 1.18e-04 | 683 | 230 | 20 | int:NUPR1 |
| Interaction | VCAM1 interactions | MYH10 ACTB RPS11 MCM6 DDX5 FASN PI4KA SNU13 ALDOA GCN1 VCP DDX17 PRKN PCBP1 PCBP2 CTSG | 1.20e-04 | 475 | 230 | 16 | int:VCAM1 |
| Interaction | CREB3L4 interactions | 1.23e-04 | 23 | 230 | 4 | int:CREB3L4 | |
| Interaction | DEFA6 interactions | 1.23e-04 | 23 | 230 | 4 | int:DEFA6 | |
| Interaction | HEXIM1 interactions | ACTBL2 ACTA1 ACTA2 ACTB RPS11 ACTC1 ACTG1 ACTG2 POTEKP DDX5 POTEE FASN SNU13 SCFD1 ALDOA VCP CAD PCBP3 DDX17 POTEF POLRMT CLEC14A PCBP1 PCBP2 | 1.29e-04 | 913 | 230 | 24 | int:HEXIM1 |
| Interaction | PLEC interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 KEAP1 PAN2 VCP DDX17 VIRMA TKT PRKN PCBP1 | 1.34e-04 | 430 | 230 | 15 | int:PLEC |
| Interaction | TOP3B interactions | MYH10 EPPK1 TMC6 APBB3 ACTG1 FGFRL1 PFAS TMCO6 SFI1 ZZEF1 TRRAP FASN PI4KA CASKIN1 DLAT TLN2 GCN1 PLXNA3 CAD SH3RF1 WNT7B AOC2 POLRMT ADGRA2 CDC42BPB MYOF PWWP2B CTDP1 LRP3 PRKN PKN1 LTK AGRN | 1.45e-04 | 1470 | 230 | 33 | int:TOP3B |
| Interaction | PDCL3 interactions | 1.50e-04 | 100 | 230 | 7 | int:PDCL3 | |
| Interaction | LGALS9 interactions | MYH10 ACTA1 ACTB RPS11 SLC38A5 DDX5 FASN DLAT SCFD1 ALDOA VCP CAD DDX17 IPO7 CASK DNAJA3 PCBP1 PCBP2 | 1.51e-04 | 588 | 230 | 18 | int:LGALS9 |
| Interaction | ARHGAP24 interactions | MYH10 ACTB ACTG1 MCM6 DDX5 DLAT SARDH VCP CAD DDX17 IPO7 PCDHA4 CBS TKT ZNF540 PANK4 | 1.56e-04 | 486 | 230 | 16 | int:ARHGAP24 |
| Interaction | DUSP10 interactions | 1.60e-04 | 71 | 230 | 6 | int:DUSP10 | |
| Interaction | ANGPTL8 interactions | 1.66e-04 | 10 | 230 | 3 | int:ANGPTL8 | |
| Interaction | TFE3 interactions | ACTBL2 ACTB RPS11 ACTC1 ACTG1 PFAS DDX5 SNU13 ALDOA VCP TKT PCBP1 PCBP2 | 1.73e-04 | 344 | 230 | 13 | int:TFE3 |
| Cytoband | 6p22.3-p22.1 | 1.64e-04 | 4 | 241 | 2 | 6p22.3-p22.1 | |
| Cytoband | 16p13.11 | 2.34e-04 | 23 | 241 | 3 | 16p13.11 | |
| GeneFamily | Actins | 3.07e-13 | 6 | 151 | 6 | 929 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.28e-05 | 161 | 151 | 8 | 593 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 1.54e-04 | 13 | 151 | 3 | 685 | |
| GeneFamily | Myosin heavy chains | 2.41e-04 | 15 | 151 | 3 | 1098 | |
| GeneFamily | Immunoglobulin like domain containing | 1.20e-03 | 193 | 151 | 7 | 594 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 1.42e-03 | 7 | 151 | 2 | 785 | |
| GeneFamily | Plexins | 2.40e-03 | 9 | 151 | 2 | 683 | |
| GeneFamily | Collectins | 2.98e-03 | 10 | 151 | 2 | 491 | |
| Coexpression | GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_UP | FGFRL1 RCBTB2 F5 MMP1 PIF1 MPO SFTPB GRM7 CLEC14A LPL IL1RL1 CTSG | 2.82e-07 | 200 | 235 | 12 | M3568 |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP | 1.41e-05 | 200 | 235 | 10 | M7519 | |
| Coexpression | LEE_CALORIE_RESTRICTION_MUSCLE_UP | 2.49e-05 | 39 | 235 | 5 | M1572 | |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM | 3.08e-05 | 67 | 235 | 6 | M1686 | |
| Coexpression | LEE_CALORIE_RESTRICTION_MUSCLE_UP | 4.05e-05 | 43 | 235 | 5 | MM669 | |
| Coexpression | GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 4.14e-05 | 182 | 235 | 9 | M9154 | |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM | 4.29e-05 | 71 | 235 | 6 | MM1210 | |
| Coexpression | ABRAMSON_INTERACT_WITH_AIRE | 4.53e-05 | 44 | 235 | 5 | M2536 | |
| Coexpression | GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP | 5.33e-05 | 188 | 235 | 9 | M6819 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_100 | 7.48e-06 | 26 | 228 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_J_100_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#3_top-relative-expression-ranked_100 | 1.10e-05 | 28 | 228 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_B_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#3_top-relative-expression-ranked_100 | 1.61e-05 | 15 | 228 | 4 | gudmap_developingLowerUrinaryTract_P1_ureter_100_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#3_top-relative-expression-ranked_100 | 3.52e-05 | 18 | 228 | 4 | gudmap_developingKidney_e15.5_Podocyte cells_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_100 | 4.42e-05 | 19 | 228 | 4 | gudmap_developingLowerUrinaryTract_adult_bladder_100_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.06e-05 | 92 | 228 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k1 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-08 | 178 | 235 | 10 | 40bd605b801d9ae76cffc8f62836092fc2b06812 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.61e-08 | 188 | 235 | 10 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | MYH10 MYH11 ACTA2 ACTG2 ACSM3 MXRA8 MMP23B WFDC1 ADAMTS13 LRP3 | 1.18e-07 | 200 | 235 | 10 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.18e-07 | 200 | 235 | 10 | 04699d1149a143b96d6f292c0d70c4d3e6dfc611 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 3.16e-07 | 170 | 235 | 9 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-07 | 178 | 235 | 9 | 01c90c3952220cc4d6a7ed9c4d575fe4f2f80fd1 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-07 | 182 | 235 | 9 | 41a7543c8b703441ff6ac2307faffe5f798b2c41 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-07 | 182 | 235 | 9 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-07 | 182 | 235 | 9 | 81c394959414173016426961478f670cd822f8b3 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 5.87e-07 | 183 | 235 | 9 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 5.87e-07 | 183 | 235 | 9 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-T_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-07 | 184 | 235 | 9 | 185b49630da61cbf45c0926d1b992943296d2a54 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 7.35e-07 | 188 | 235 | 9 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.35e-07 | 188 | 235 | 9 | 74f7d216209cabdc96b2d46685b0ae017fdcc8fc | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.68e-07 | 189 | 235 | 9 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.15e-07 | 193 | 235 | 9 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-06 | 197 | 235 | 9 | 470e23dee4ca35e1fd021b7cdd58fcbc90639837 | |
| ToppCell | Fibroblast|World / shred by cell class for bronchial biopsy | 1.08e-06 | 197 | 235 | 9 | 8bf9846228b6b6721b10375fe54a2fb389ff64a6 | |
| ToppCell | VE-CD8-proli_CD4|VE / Condition, Cell_class and T cell subcluster | 1.10e-06 | 101 | 235 | 7 | 5293f15b5ed340e6d0282b56de13752eabeef8dd | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_monocytic-monocyte-promonocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.13e-06 | 198 | 235 | 9 | a11de3836fc1575bec5f6c701836fe2fb5a1027a | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.18e-06 | 199 | 235 | 9 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.18e-06 | 199 | 235 | 9 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.18e-06 | 199 | 235 | 9 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.23e-06 | 200 | 235 | 9 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 1.23e-06 | 200 | 235 | 9 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 1.23e-06 | 200 | 235 | 9 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.23e-06 | 200 | 235 | 9 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.23e-06 | 200 | 235 | 9 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | distal-mesenchymal-Airway_Smooth_Muscle-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.23e-06 | 200 | 235 | 9 | bc969a956f62570419a5faaf0ab0fd17b343c5ca | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 1.23e-06 | 200 | 235 | 9 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.23e-06 | 200 | 235 | 9 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 2.32e-06 | 161 | 235 | 8 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-06 | 163 | 235 | 8 | fd35f1237c23367753ac2bc3e893f0e3c714129c | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 2.79e-06 | 165 | 235 | 8 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-CMP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.19e-06 | 168 | 235 | 8 | e223bd7ae2a28c007e8b365f30d50d3bee83ba38 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.50e-06 | 176 | 235 | 8 | 1f8d5a48fedbb4c86272c9b5a0f1ef573350357b | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.69e-06 | 177 | 235 | 8 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.09e-06 | 179 | 235 | 8 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-06 | 181 | 235 | 8 | 3fe648db1cb8326066d8bde3ca1287c5c9af19bd | |
| ToppCell | Pericytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.76e-06 | 182 | 235 | 8 | 46c213597445b1f4f09dc367f27702d24b201daf | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-06 | 182 | 235 | 8 | c84f44391932080df31c8765e363c3dff64b2bd1 | |
| ToppCell | Pericytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 5.99e-06 | 183 | 235 | 8 | d04deef7cd4e1738227a6593b84874ce0168c773 | |
| ToppCell | Pericytes-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.99e-06 | 183 | 235 | 8 | 4617b18da8d699a44e4c47980197b1e7eb951470 | |
| ToppCell | 21-Trachea-Mesenchymal-Airway_Smooth_Muscle|Trachea / Age, Tissue, Lineage and Cell class | 6.24e-06 | 184 | 235 | 8 | 86a96cd88e50eacad1f0badfbbf6dc626f41725e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.24e-06 | 184 | 235 | 8 | 590fb32bb1f348ea5fa2aece30ebe1e212512991 | |
| ToppCell | (7)_MNP-(7)_DC_plasmacytoid|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.49e-06 | 185 | 235 | 8 | 9f67f652488e17075a372e2a2e1100f6d0af6d7d | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 185 | 235 | 8 | 3f1aa91efae2d00320d126087cce1431ad5f26ea | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-06 | 187 | 235 | 8 | 5fada3c5a58c1890029ccbfff2608b33f8cd2df7 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-06 | 187 | 235 | 8 | 766e808138fc2cd623c2e6d57fcb5c7378da0e03 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-06 | 187 | 235 | 8 | f49d06600060deeb2fc1b1da5b93496535f20104 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.02e-06 | 187 | 235 | 8 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | 7.02e-06 | 187 | 235 | 8 | be9fce9e74b2f170a2067f1b31d802912a578329 | |
| ToppCell | Pericytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 7.02e-06 | 187 | 235 | 8 | 35f25780d113f60bf4c13749013c09612ee4ff41 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.02e-06 | 187 | 235 | 8 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.30e-06 | 188 | 235 | 8 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.59e-06 | 189 | 235 | 8 | b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 7.59e-06 | 189 | 235 | 8 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.89e-06 | 190 | 235 | 8 | e102622f05c7f3e1bd8b224ea159d57033793ee0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.20e-06 | 191 | 235 | 8 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.20e-06 | 191 | 235 | 8 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.20e-06 | 191 | 235 | 8 | 2a107e9096eb58b81b3da61547904d85754f6b2f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.20e-06 | 191 | 235 | 8 | d35692c652977500a3c36aa26c347a072b71e441 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.20e-06 | 191 | 235 | 8 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.85e-06 | 193 | 235 | 8 | 5182284dfa7c94027e94172e08f78c86b95d63f4 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.85e-06 | 193 | 235 | 8 | 4f7bab0115469c855160636d168bd6e5d4e2dd2f | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Lpl_(Layer_2/3)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.34e-06 | 92 | 235 | 6 | dfe63bb979f0382163955b32909ffab1de37685a | |
| ToppCell | myeloid-CD34+_Monoblast|World / Lineage and Cell class | 9.53e-06 | 195 | 235 | 8 | 2065de671988ecade90a7be21af9b0912d49f8fc | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.90e-06 | 196 | 235 | 8 | 9d18381d7aaa063094a5df769a04c73350471525 | |
| ToppCell | (5)_Fibroblast-K_(Pericytes)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.90e-06 | 196 | 235 | 8 | e3c89c5bd674289738d5590ebfd30c605f5156a5 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.90e-06 | 196 | 235 | 8 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.90e-06 | 196 | 235 | 8 | afddacc0fb8b9c73dad5333137deb471a6ebdc06 | |
| ToppCell | Pericytes|World / shred by cell class for parenchyma | 9.90e-06 | 196 | 235 | 8 | 8e7ecbe77d312a7fc6aadd8fd52c13dd1834cc7e | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.90e-06 | 196 | 235 | 8 | 541b1fcf509e362f6f48720046cb5378aaf7c591 | |
| ToppCell | metastatic_Brain-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 9.90e-06 | 196 | 235 | 8 | c17e105e47446a48aa06e1a3810828e20aa56ea9 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.90e-06 | 196 | 235 | 8 | a52cb512c6173be92aa9c4d96e2abbc32f45478d | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-neutrophil-promyelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.03e-05 | 197 | 235 | 8 | 6fe4a9f67291a7e4260984e901d069ff1746d0be | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 1.03e-05 | 197 | 235 | 8 | e666f6580e9a20b5e550f02125706db17eec8510 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-05 | 197 | 235 | 8 | 78d45d11820ec379942c4c3defd619d5f8cc8e1f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-05 | 197 | 235 | 8 | 31bc9fd679d78550541d4158568e8dd09ff29e8e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-05 | 197 | 235 | 8 | 01249bd485a3734de87ae6ed9c749597f39c6335 | |
| ToppCell | Control-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.03e-05 | 197 | 235 | 8 | 925bf0d38e4ce279fa45f455546ebd199282c0df | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_monocytic-monocyte-MOP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-05 | 198 | 235 | 8 | 3a923a2ac932fd7125f9f0836d1f06a513dc3b70 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-05 | 198 | 235 | 8 | c82a151f9f1477d4a401457173b8d72af776c137 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-05 | 198 | 235 | 8 | dc63b56bb6291e527b172d603569376286262845 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-promyelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-05 | 198 | 235 | 8 | d816bc0e986b5f4b94d348f6237bd91e10da432c | |
| ToppCell | Skin-Mesangial|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.11e-05 | 199 | 235 | 8 | bcb78838a91cc7828680fb413fbacdb091c5fac0 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-05 | 199 | 235 | 8 | 056a28c36cd58dc695a5ae6f29b62135d6aad819 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 199 | 235 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | ASK454-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.11e-05 | 199 | 235 | 8 | cbfabf8e895abe454606b990f99e3738f4263ffe | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-05 | 199 | 235 | 8 | 534dcfe8b65ad92bb8d749d1c7036ad4807e09cd | |
| ToppCell | 3'-Parenchyma_lung|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-05 | 199 | 235 | 8 | bc064ccfec8c1e96079b89b05aeebddf48bc87f3 | |
| ToppCell | 11.5-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 1.11e-05 | 199 | 235 | 8 | 1a8c77d241bd817a195e1532fd25f51358cb1ff1 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-05 | 199 | 235 | 8 | b2508bf591720830e8e3494b1337aab14539956d | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-05 | 199 | 235 | 8 | 7c272a1aa7f3e931ad5d20809719d85b3bce4cb0 | |
| ToppCell | ASK454-Immune-B_cell|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.11e-05 | 199 | 235 | 8 | b9b0ae81b9e7e35023c73d3b936e88167461ba54 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.15e-05 | 200 | 235 | 8 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.15e-05 | 200 | 235 | 8 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | proximal-mesenchymal-Airway_Smooth_Muscle-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.15e-05 | 200 | 235 | 8 | 6fa339666c4032b29ac521e88f0e917a57013cde | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Neuron|1m / Sample Type, Dataset, Time_group, and Cell type. | 1.15e-05 | 200 | 235 | 8 | be1e153119ca4946b4eaef6037e8465f5c00ca6f | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-05 | 200 | 235 | 8 | fe493b0454a20498e9ada482bf55de64519f6c35 | |
| Computational | Muscle genes. | 5.93e-06 | 37 | 135 | 6 | MODULE_512 | |
| Computational | Genes in the cancer module 387. | 3.15e-05 | 49 | 135 | 6 | MODULE_387 | |
| Computational | Genes in the cancer module 329. | 3.98e-05 | 51 | 135 | 6 | MODULE_329 | |
| Computational | Blood cells and cancer expression cancer. | PI4K2B CXCL10 SLITRK1 ALDOA PIF1 KLHL4 SLC11A2 GPR26 MXRA8 RNF213 FBXO11 LRRC4C LPL LRP3 IL1RL1 DNAH11 | 2.50e-04 | 468 | 135 | 16 | MODULE_179 |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.91e-04 | 50 | 135 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_31_ALVEOLAR | |
| Computational | Genes in the cancer module 255. | PI4K2B CXCL10 SLITRK1 ALDOA PIF1 KLHL4 SLC11A2 GPR26 MXRA8 RNF213 FBXO11 LRRC4C LRP3 IL1RL1 DNAH11 | 5.14e-04 | 450 | 135 | 15 | MODULE_255 |
| Computational | Response to DNA damage. | 5.73e-04 | 187 | 135 | 9 | MODULE_244 | |
| Computational | Blood cells and cancer expression clusters. | PI4K2B CXCL10 SLITRK1 PIF1 KLHL4 SLC11A2 GPR26 MXRA8 RNF213 FBXO11 LRRC4C LRP3 IL1RL1 DNAH11 | 5.84e-04 | 407 | 135 | 14 | MODULE_532 |
| Computational | Neighborhood of DDX11 | 7.68e-04 | 156 | 135 | 8 | MORF_DDX11 | |
| Drug | Nsc687160 | 3.20e-10 | 18 | 234 | 7 | CID005459290 | |
| Drug | tolytoxin | 5.02e-10 | 19 | 234 | 7 | CID006440827 | |
| Drug | quinacrine | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 CRYBG1 MMP1 PLD4 MPO TBXAS1 MMP23B CBS SLC5A2 LPL LTK | 6.49e-10 | 243 | 234 | 17 | CID000000237 |
| Drug | NSC312786 | 1.14e-09 | 21 | 234 | 7 | CID000329495 | |
| Drug | AC1L8NVR | 1.14e-09 | 21 | 234 | 7 | CID000384633 | |
| Drug | N,N'-p-phenylenedimaleimide | 1.59e-09 | 34 | 234 | 8 | CID000076765 | |
| Drug | NSC107658 | MYH10 MYH11 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 MMP1 PLD4 MPO AOC2 SLC5A2 LIMK1 MYH14 PKN1 CTSG | 3.22e-09 | 306 | 234 | 18 | CID000002919 |
| Drug | azaspiracid | 1.84e-08 | 30 | 234 | 7 | CID006451158 | |
| Drug | m2-19 | 2.68e-08 | 19 | 234 | 6 | CID000079129 | |
| Drug | AC1L1HS4 | 2.99e-08 | 32 | 234 | 7 | CID000004267 | |
| Drug | 1tjp | PECAM1 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 MOS MPO PRSS33 CTDP1 | 3.26e-08 | 116 | 234 | 11 | CID005459371 |
| Drug | C18:1n-7 | 3.75e-08 | 92 | 234 | 10 | CID000122325 | |
| Drug | 1,N6-ethenoadenosine 5'-diphosphate | 4.70e-08 | 34 | 234 | 7 | CID000001312 | |
| Drug | NSC106399 | 4.81e-08 | 51 | 234 | 8 | CID000002887 | |
| Drug | sulphoxide | 9.21e-08 | 101 | 234 | 10 | CID000008442 | |
| Drug | AC1L1GZB | MYH11 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 NOP9 MMP1 TBXAS1 PRSS33 GSS | 1.69e-07 | 167 | 234 | 12 | CID000003908 |
| Drug | epsilon-ATP | 1.85e-07 | 41 | 234 | 7 | CID000162262 | |
| Drug | N-acetyl-S-geranylgeranyl-L-cysteine | 2.20e-07 | 42 | 234 | 7 | CID000002067 | |
| Drug | enantio-PAF-C16 | ACTBL2 PECAM1 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 NOP9 MMP1 MPO TBXAS1 MMP23B CTSG | 2.56e-07 | 244 | 234 | 14 | CID000002499 |
| Drug | 6-trans-leukotriene B4 | MYH11 ACTBL2 PECAM1 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 NOP9 PLD4 MPO TBXAS1 CTSG | 2.97e-07 | 247 | 234 | 14 | CID000000169 |
| Drug | AC1L8FNU | 3.07e-07 | 44 | 234 | 7 | CID000425429 | |
| Drug | blebbistatin | 3.42e-07 | 116 | 234 | 10 | CID003476986 | |
| Drug | CID5288653 | 3.45e-07 | 28 | 234 | 6 | CID005288653 | |
| Drug | B0683 | 3.70e-07 | 117 | 234 | 10 | CID006398969 | |
| Drug | 5-IAF | 3.80e-07 | 66 | 234 | 8 | CID000123822 | |
| Drug | Pb m | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 NOP9 DDX17 SLC11A2 | 4.01e-07 | 118 | 234 | 10 | CID006327255 |
| Drug | mDia | 4.99e-07 | 93 | 234 | 9 | CID000128346 | |
| Drug | AC1L1ERT | 5.38e-07 | 69 | 234 | 8 | CID000002920 | |
| Drug | NpCaM | 5.70e-07 | 48 | 234 | 7 | CID000122259 | |
| Drug | AC1Q6LQU | 5.70e-07 | 48 | 234 | 7 | CID000072380 | |
| Drug | AC1MNW2N | 6.02e-07 | 70 | 234 | 8 | CID003359490 | |
| Drug | CoA group | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 HMGCR FASN ACSM3 DLAT SARDH SOAT2 AGPAT1 ARMC1 GSS LPL ACSM2A | 6.13e-07 | 433 | 234 | 18 | CID000000317 |
| Drug | foscarnet | ERVK-6 TSPOAP1 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 PFAS MMP23B POLRMT POLG2 | 6.79e-07 | 190 | 234 | 12 | CID000003414 |
| Drug | magnesium | ERVK-6 CNNM2 MYH11 MRS2 ACTBL2 ACTA1 ACTA2 ACTB GATB ACTC1 ACTG1 ACTG2 FGFRL1 DGKH HMGCR DFFB AK5 DLAT SNU13 ALAD MMP1 KIF22 CAD MMP23B POLRMT GRIA1 ERN2 GSS FARS2 TKT CTDP1 CARD11 PKN1 DNAH11 | 7.95e-07 | 1325 | 234 | 34 | CID000000888 |
| Drug | AC1LADJ6 | 9.85e-07 | 130 | 234 | 10 | CID000486032 | |
| Drug | SIRIUS | 1.26e-06 | 77 | 234 | 8 | CID000091750 | |
| Drug | AC1OAGGW | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 DGKH KCND1 PI4KA PLD4 PITPNM1 | 1.37e-06 | 203 | 234 | 12 | CID006857364 |
| Drug | 3-methylhistidine | 1.48e-06 | 55 | 234 | 7 | CID000064969 | |
| Drug | AC1L9EF8 | 1.54e-06 | 79 | 234 | 8 | CID000443315 | |
| Drug | AC1NSKFN | 1.66e-06 | 36 | 234 | 6 | CID005311324 | |
| Drug | dihydrocytochalasin B | 2.13e-06 | 58 | 234 | 7 | CID000003064 | |
| Drug | dithiotreitol | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 HMGCR GLRX ALAD MMP1 KCNK17 MPO CBS SIRT4 GSS CARD11 | 2.51e-06 | 430 | 234 | 17 | CID000019001 |
| Drug | candesartan cilexetil | 2.66e-06 | 145 | 234 | 10 | CID000002540 | |
| Drug | HU-211 | 2.79e-06 | 114 | 234 | 9 | CID000107778 | |
| Drug | bistheonellide A | 3.39e-06 | 11 | 234 | 4 | CID006441172 | |
| Drug | Viroisin | 3.39e-06 | 11 | 234 | 4 | CID000119538 | |
| Drug | AC1L1IZ2 | MYH10 MYH11 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 AK5 DLAT VCP GSS MYH14 | 3.49e-06 | 304 | 234 | 14 | CID000004795 |
| Drug | oryzalin | 3.76e-06 | 63 | 234 | 7 | CID000029393 | |
| Drug | AC1L22RD | 4.51e-06 | 91 | 234 | 8 | CID000065183 | |
| Drug | AGEPC | ACTBL2 PECAM1 ACTA1 ACTA2 ACTB ACTC1 ACTG1 SLC38A5 ACTG2 NOP9 PLD4 MPO TBXAS1 PRSS33 CTSG | 4.62e-06 | 356 | 234 | 15 | CID000461545 |
| Drug | thalidomide | ACTBL2 PECAM1 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 RCBTB2 MPO DRD4 LIMK1 | 4.78e-06 | 229 | 234 | 12 | CID000005426 |
| Drug | BFDGE | 5.05e-06 | 12 | 234 | 4 | CID000091511 | |
| Drug | CaCl2 | 5.13e-06 | 156 | 234 | 10 | CID000024854 | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A | ZZEF1 SCML2 TLN2 SFTPB ERN2 SYDE1 SLC5A2 TRIM33 KDM8 AGRN CAPN15 | 5.65e-06 | 194 | 234 | 11 | 4242_DN |
| Drug | arsenic | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 KEAP1 GLRX ALAD MMP1 GSS CTSG | 5.68e-06 | 274 | 234 | 13 | CID005359596 |
| Drug | AC1L1GXW | 5.75e-06 | 94 | 234 | 8 | CID000003891 | |
| Drug | manidipine | 6.22e-06 | 95 | 234 | 8 | CID000004008 | |
| Drug | K-Cl | ERVK-6 MYH10 MYH11 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 HMGCR DUS2 NOP9 ACSM3 PLD4 MYH14 CARD11 PCBP1 CAPN15 | 7.06e-06 | 567 | 234 | 19 | CID000004873 |
| Drug | caged ATP | 7.66e-06 | 70 | 234 | 7 | CID000123806 | |
| Drug | NSC3096 | 7.85e-06 | 98 | 234 | 8 | CID000002832 | |
| Drug | NSC613009 | 8.22e-06 | 130 | 234 | 9 | CID000003800 | |
| Drug | kabiramide C | 1.00e-05 | 14 | 234 | 4 | CID005288658 | |
| Drug | L-Carnosine | 1.01e-05 | 73 | 234 | 7 | CID000009369 | |
| Drug | beryllium fluoride | 1.13e-05 | 103 | 234 | 8 | CID000024589 | |
| Drug | khellin | 1.15e-05 | 171 | 234 | 10 | CID000003828 | |
| Drug | prostacyclin sodium salt | PECAM1 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 MPO TBXAS1 ADAMTS13 LPL CTSG | 1.16e-05 | 250 | 234 | 12 | CID000000159 |
| Drug | AC1NRBPQ | 1.26e-05 | 137 | 234 | 9 | CID005288569 | |
| Drug | AC1L1BDQ | 1.28e-05 | 173 | 234 | 10 | CID000001394 | |
| Drug | FTY720 | 1.40e-05 | 106 | 234 | 8 | CID000107969 | |
| Drug | NSC60597 | 1.50e-05 | 140 | 234 | 9 | CID000003327 | |
| Drug | 0-to | 1.58e-05 | 141 | 234 | 9 | CID000002051 | |
| Drug | AC1Q3ZOL | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 DRD4 GRIA1 PRSS33 GRM7 ADGRE5 | 1.59e-05 | 258 | 234 | 12 | CID000002376 |
| Drug | DE gel | 1.77e-05 | 143 | 234 | 9 | CID000008146 | |
| Drug | AC1NQAAM | 1.87e-05 | 144 | 234 | 9 | CID005192834 | |
| Drug | AC1Q5THZ | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 DGKH NOP9 MMP1 PLD4 MPO TBXAS1 SIRT4 LPL CARD11 CTSG | 1.90e-05 | 502 | 234 | 17 | CID000001959 |
| Drug | phenylmethylsulfonyl fluoride | ERVK-6 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 MMP1 PREP LPL CTSG | 1.92e-05 | 263 | 234 | 12 | CID000004784 |
| Drug | NS-398 | ACTBL2 PECAM1 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 NOP9 MMP1 MPO TBXAS1 | 2.00e-05 | 264 | 234 | 12 | CID000004553 |
| Drug | plakin | 2.19e-05 | 82 | 234 | 7 | CID000018752 | |
| Drug | NSC350593 | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 NOP9 PLD4 MPO AOC2 CTSG | 2.40e-05 | 269 | 234 | 12 | CID000004364 |
| Drug | formamide | 2.77e-05 | 85 | 234 | 7 | CID000000713 | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | 2.87e-05 | 190 | 234 | 10 | 4307_DN | |
| Drug | D-myo-inositol 1,4-bisphosphate | 2.99e-05 | 86 | 234 | 7 | CID000000805 | |
| Drug | Co-protoporphyrin IX | 3.06e-05 | 118 | 234 | 8 | CID000004972 | |
| Drug | eye gene | MYH10 MYH11 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 PLD4 WFDC1 MYH14 TRIM17 CARD11 | 3.09e-05 | 369 | 234 | 14 | CID000004782 |
| Drug | TCNB | 3.25e-05 | 119 | 234 | 8 | CID000008330 | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; PC3; HT_HG-U133A | ZZEF1 PLXNB1 SFTPB WNT7A WNT7B SYDE1 SLC5A2 KDM8 AGRN CAPN15 | 3.28e-05 | 193 | 234 | 10 | 4226_DN |
| Drug | DFMO | 3.36e-05 | 155 | 234 | 9 | CID000003009 | |
| Drug | erythrulose | 3.73e-05 | 19 | 234 | 4 | CID000162406 | |
| Drug | 5'IATR | 3.73e-05 | 19 | 234 | 4 | CID000074997 | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; PC3; HT_HG-U133A | 3.74e-05 | 196 | 234 | 10 | 2073_UP | |
| Drug | bromodeoxyuridine | PECAM1 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 F5 DUS2 MKI67 ALAD ITCH GRIA1 TKT | 3.79e-05 | 376 | 234 | 14 | CID000006035 |
| Drug | Formyl | 3.81e-05 | 238 | 234 | 11 | CID000123370 | |
| Drug | AC1NSKHI | 3.83e-05 | 61 | 234 | 6 | CID005311358 | |
| Drug | chlorpromazine | 3.91e-05 | 197 | 234 | 10 | CID000002726 | |
| Drug | Piperidolate hydrochloride [129-77-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 3.91e-05 | 197 | 234 | 10 | 3551_UP | |
| Drug | Morantel tartrate [26155-31-7]; Down 200; 10.8uM; PC3; HT_HG-U133A | 3.91e-05 | 197 | 234 | 10 | 1798_DN | |
| Drug | Benzonatate [104-31-4]; Up 200; 6.6uM; HL60; HT_HG-U133A | 3.91e-05 | 197 | 234 | 10 | 1843_UP | |
| Drug | AC1NRCMD | 4.01e-05 | 90 | 234 | 7 | CID005289074 | |
| Drug | Fusaric acid [536-69-6]; Down 200; 22.4uM; PC3; HT_HG-U133A | 4.08e-05 | 198 | 234 | 10 | 3986_DN | |
| Drug | Panthenol (D) [81-13-0]; Down 200; 19.4uM; PC3; HT_HG-U133A | ACTG2 SEPTIN6 DUS2 DMBT1 ITCH DDX17 DYNC2H1 SYDE1 CTDP1 AGRN | 4.08e-05 | 198 | 234 | 10 | 1802_DN |
| Disease | Moyamoya disease (implicated_via_orthology) | 9.73e-18 | 8 | 224 | 8 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 9.73e-18 | 8 | 224 | 8 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 9.73e-18 | 8 | 224 | 8 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 9.73e-18 | 8 | 224 | 8 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 4.32e-16 | 10 | 224 | 8 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 4.32e-16 | 10 | 224 | 8 | DOID:13832 (implicated_via_orthology) | |
| Disease | bacterial pneumonia (biomarker_via_orthology) | 4.57e-08 | 14 | 224 | 5 | DOID:874 (biomarker_via_orthology) | |
| Disease | newborn respiratory distress syndrome (biomarker_via_orthology) | 8.49e-06 | 6 | 224 | 3 | DOID:12716 (biomarker_via_orthology) | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 1.02e-05 | 65 | 224 | 6 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | coronary artery disease (is_implicated_in) | 1.16e-05 | 100 | 224 | 7 | DOID:3393 (is_implicated_in) | |
| Disease | newborn respiratory distress syndrome (is_implicated_in) | 1.48e-05 | 7 | 224 | 3 | DOID:12716 (is_implicated_in) | |
| Disease | Colonic Neoplasms | 2.23e-05 | 152 | 224 | 8 | C0009375 | |
| Disease | Malignant tumor of colon | 3.09e-05 | 159 | 224 | 8 | C0007102 | |
| Disease | interstitial lung disease (is_marker_for) | 3.61e-05 | 25 | 224 | 4 | DOID:3082 (is_marker_for) | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 5.74e-05 | 2 | 224 | 2 | C1855722 | |
| Disease | Baraitser-Winter syndrome | 5.74e-05 | 2 | 224 | 2 | cv:C1853623 | |
| Disease | Moyamoya disease 1 | 5.74e-05 | 2 | 224 | 2 | C2931384 | |
| Disease | Fryns-Aftimos Syndrome | 5.74e-05 | 2 | 224 | 2 | C1853623 | |
| Disease | thoracic aortic aneurysm (is_implicated_in) | 6.81e-05 | 11 | 224 | 3 | DOID:14004 (is_implicated_in) | |
| Disease | Hypoxemia | 1.11e-04 | 33 | 224 | 4 | C0700292 | |
| Disease | Hypoxia | 1.11e-04 | 33 | 224 | 4 | C0242184 | |
| Disease | Anoxemia | 1.11e-04 | 33 | 224 | 4 | C0003129 | |
| Disease | Anoxia | 1.11e-04 | 33 | 224 | 4 | C0003130 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.26e-04 | 145 | 224 | 7 | DOID:1289 (implicated_via_orthology) | |
| Disease | obesity (biomarker_via_orthology) | 1.37e-04 | 147 | 224 | 7 | DOID:9970 (biomarker_via_orthology) | |
| Disease | pulse pressure measurement | CNNM2 MYH11 ATP8B4 LYPLAL1 PECAM1 ACTA2 DDX5 FASN MYPN TLN2 MMP1 PIF1 TBXAS1 PCBP3 WDR7 DYNC2H1 WNT7A AGPAT1 RNF213 PCDHA4 CEP164 LIMK1 GALNT9 LPL | 1.63e-04 | 1392 | 224 | 24 | EFO_0005763 |
| Disease | importin subunit alpha-1 measurement | 1.71e-04 | 3 | 224 | 2 | EFO_0020467 | |
| Disease | Disease Exacerbation | 2.79e-04 | 165 | 224 | 7 | C0235874 | |
| Disease | beta-nerve growth factor measurement | 2.89e-04 | 42 | 224 | 4 | EFO_0008035 | |
| Disease | Megacystis microcolon intestinal hypoperistalsis syndrome | 3.41e-04 | 4 | 224 | 2 | C1608393 | |
| Disease | liver cirrhosis (is_marker_for) | 4.09e-04 | 82 | 224 | 5 | DOID:5082 (is_marker_for) | |
| Disease | level of leukocyte immunoglobulin-like receptor subfamily B member 4 in blood serum | 5.65e-04 | 5 | 224 | 2 | OBA_2042200 | |
| Disease | intermediate coronary syndrome (is_implicated_in) | 5.65e-04 | 5 | 224 | 2 | DOID:8805 (is_implicated_in) | |
| Disease | megacystis-microcolon-intestinal hypoperistalsis syndrome (is_implicated_in) | 5.65e-04 | 5 | 224 | 2 | DOID:0060610 (is_implicated_in) | |
| Disease | Keratosis Blennorrhagica | 5.65e-04 | 5 | 224 | 2 | C0022594 | |
| Disease | Keratosis | 5.65e-04 | 5 | 224 | 2 | C0022593 | |
| Disease | level of prosaposin in blood serum | 5.65e-04 | 5 | 224 | 2 | OBA_2044552 | |
| Disease | muscular disease (implicated_via_orthology) | 5.65e-04 | 5 | 224 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | ras-related protein Rab-26 measurement | 5.65e-04 | 5 | 224 | 2 | EFO_0801989 | |
| Disease | low-density lipoprotein receptor-related protein 1, soluble measurement | 5.65e-04 | 5 | 224 | 2 | EFO_0801772 | |
| Disease | Keratoma | 5.65e-04 | 5 | 224 | 2 | C0086501 | |
| Disease | Moyamoya disease (is_implicated_in) | 5.65e-04 | 5 | 224 | 2 | DOID:13099 (is_implicated_in) | |
| Disease | myeloperoxidase (MPO)-DNA complex measurement | 5.98e-04 | 22 | 224 | 3 | EFO_0011039 | |
| Disease | systemic scleroderma (is_marker_for) | 7.07e-04 | 53 | 224 | 4 | DOID:418 (is_marker_for) | |
| Disease | bipolar I disorder | 7.49e-04 | 141 | 224 | 6 | EFO_0009963 | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 7.77e-04 | 24 | 224 | 3 | DOID:3827 (biomarker_via_orthology) | |
| Disease | Mammary Carcinoma, Animal | 7.77e-04 | 142 | 224 | 6 | C1257925 | |
| Disease | Animal Mammary Neoplasms | 7.77e-04 | 142 | 224 | 6 | C0024667 | |
| Disease | Tinnitus, wellbeing measurement | 8.41e-04 | 96 | 224 | 5 | EFO_0007869, HP_0000360 | |
| Disease | ERO1-like protein alpha measurement | 8.43e-04 | 6 | 224 | 2 | EFO_0801582 | |
| Disease | indoleacetylglutamine measurement | 8.43e-04 | 6 | 224 | 2 | EFO_0800035 | |
| Disease | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 measurement | 8.43e-04 | 6 | 224 | 2 | EFO_0801372 | |
| Disease | pulmonary alveolar proteinosis (is_marker_for) | 8.43e-04 | 6 | 224 | 2 | DOID:12120 (is_marker_for) | |
| Disease | Gilles de la Tourette syndrome (is_implicated_in) | 8.43e-04 | 6 | 224 | 2 | DOID:11119 (is_implicated_in) | |
| Disease | protocadherin beta-4 measurement | 8.43e-04 | 6 | 224 | 2 | EFO_0801976 | |
| Disease | indolepropionate measurement | 8.43e-04 | 6 | 224 | 2 | EFO_0021016 | |
| Disease | torsin-1A-interacting protein 1 measurement | 8.43e-04 | 6 | 224 | 2 | EFO_0802137 | |
| Disease | muscular disease (is_implicated_in) | 8.43e-04 | 6 | 224 | 2 | DOID:0080000 (is_implicated_in) | |
| Disease | Hypertrophic Cardiomyopathy | 9.32e-04 | 57 | 224 | 4 | C0007194 | |
| Disease | myeloperoxidase measurement | 9.86e-04 | 26 | 224 | 3 | EFO_0005243 | |
| Disease | Colorectal Carcinoma | SPNS3 F5 CORO2B MKI67 PKHD1 PAN2 MMP1 MPO CAD SLC11A2 FRMPD2 ZNF540 PANK4 TENM1 | 1.02e-03 | 702 | 224 | 14 | C0009402 |
| Disease | Nemaline Myopathy, Childhood Onset | 1.17e-03 | 7 | 224 | 2 | C0546125 | |
| Disease | Uveoretinal Coloboma | 1.17e-03 | 7 | 224 | 2 | C4554007 | |
| Disease | tumor necrosis factor receptor superfamily member 6 measurement | 1.17e-03 | 7 | 224 | 2 | EFO_0010610 | |
| Disease | Mammary Neoplasms, Experimental | 1.22e-03 | 155 | 224 | 6 | C0024668 | |
| Disease | lumbar disc degeneration | 1.23e-03 | 28 | 224 | 3 | EFO_0004994 | |
| Disease | Ciliopathies | 1.55e-03 | 110 | 224 | 5 | C4277690 | |
| Disease | E3 ubiquitin-protein ligase RNF13 measurement | 1.56e-03 | 8 | 224 | 2 | EFO_0801556 | |
| Disease | nemaline myopathy (implicated_via_orthology) | 1.56e-03 | 8 | 224 | 2 | DOID:3191 (implicated_via_orthology) | |
| Disease | zinc-alpha-2-glycoprotein measurement | 1.56e-03 | 8 | 224 | 2 | EFO_0802228 | |
| Disease | pantothenate measurement | 1.56e-03 | 8 | 224 | 2 | EFO_0021034 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 4 measurement | 1.56e-03 | 8 | 224 | 2 | EFO_0801768 | |
| Disease | Carcinomatosis | 1.58e-03 | 163 | 224 | 6 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 1.58e-03 | 163 | 224 | 6 | C0205697 | |
| Disease | Undifferentiated carcinoma | 1.58e-03 | 163 | 224 | 6 | C0205698 | |
| Disease | Anaplastic carcinoma | 1.58e-03 | 163 | 224 | 6 | C0205696 | |
| Disease | Carcinoma | 1.63e-03 | 164 | 224 | 6 | C0007097 | |
| Disease | Cholestasis, Extrahepatic | 1.82e-03 | 32 | 224 | 3 | C0005398 | |
| Disease | Large cell carcinoma of lung | 1.82e-03 | 32 | 224 | 3 | C0345958 | |
| Disease | complement C1q and tumor necrosis factor-related protein 9A measurement | 1.99e-03 | 9 | 224 | 2 | EFO_0803293 | |
| Disease | dickkopf-like protein 1 measurement | 1.99e-03 | 9 | 224 | 2 | EFO_0020324 | |
| Disease | cyclin-dependent kinase 5:cyclin-dependent kinase 5 activator 1 complex measurement | 1.99e-03 | 9 | 224 | 2 | EFO_0020296 | |
| Disease | cellular retinoic acid-binding protein 1 measurement | 1.99e-03 | 9 | 224 | 2 | EFO_0801463 | |
| Disease | apolipoprotein D measurement | 1.99e-03 | 9 | 224 | 2 | EFO_0020156 | |
| Disease | bacterial pneumonia (is_marker_for) | 1.99e-03 | 9 | 224 | 2 | DOID:874 (is_marker_for) | |
| Disease | oxysterols receptor LXR-beta measurement | 1.99e-03 | 9 | 224 | 2 | EFO_0801865 | |
| Disease | interleukin-34 measurement | 1.99e-03 | 9 | 224 | 2 | EFO_0020505 | |
| Disease | Congenital ocular coloboma (disorder) | 1.99e-03 | 9 | 224 | 2 | C0009363 | |
| Disease | leucine-rich repeat serine/threonine-protein kinase 2 measurement | 1.99e-03 | 9 | 224 | 2 | EFO_0021876 | |
| Disease | response to topoisomerase inhibitor, response to antineoplastic agent | 1.99e-03 | 9 | 224 | 2 | GO_0072758, GO_0097327 | |
| Disease | Vasodilators used in cardiac diseases use measurement | 2.17e-03 | 34 | 224 | 3 | EFO_0009926 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.33e-03 | 447 | 224 | 10 | EFO_0000694, MONDO_0100096 | |
| Disease | lung disease (biomarker_via_orthology) | 2.36e-03 | 35 | 224 | 3 | DOID:850 (biomarker_via_orthology) | |
| Disease | interstitial lung disease (is_implicated_in) | 2.48e-03 | 10 | 224 | 2 | DOID:3082 (is_implicated_in) | |
| Disease | Congenital neurologic anomalies | 2.48e-03 | 10 | 224 | 2 | C0497552 | |
| Disease | Cranioschisis | 2.48e-03 | 10 | 224 | 2 | C0265541 | |
| Disease | abdominal obesity-metabolic syndrome (implicated_via_orthology) | 2.48e-03 | 10 | 224 | 2 | DOID:0060611 (implicated_via_orthology) | |
| Disease | serine/threonine-protein kinase 16 measurement | 2.48e-03 | 10 | 224 | 2 | EFO_0020724 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.48e-03 | 10 | 224 | 2 | cv:C4707243 | |
| Disease | interleukin-37 measurement | 2.48e-03 | 10 | 224 | 2 | EFO_0020506 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EVATARCVRTVPVGG | 441 | Q14137 | |
| ERAGVVRELCAQPGQ | 86 | Q9Y5B0 | |
| VVAPGAVLVRLEGCS | 101 | Q9Y5B0 | |
| QEVRRLVCGPNAIEV | 176 | Q4VNC0 | |
| VDRRVSALPVVNECG | 376 | Q9UGI9 | |
| DGQVITIGNERFRCP | 246 | P68133 | |
| CGVGNLTEPVAVSLR | 686 | Q96PE1 | |
| GQVITIGNERFRCPE | 246 | Q562R1 | |
| QVITIGNERFRCPEA | 246 | Q9BYX7 | |
| QVITIGNERFRCPEA | 246 | P60709 | |
| QVITIGNERFRCPEA | 246 | P63261 | |
| CGLQRGDRVAVVLPR | 101 | Q08AH3 | |
| ADDRVNPCIGGVILF | 66 | P04075 | |
| RIIQERNGVLPDCLT | 126 | Q96G28 | |
| IENEGGQVGLRCRLV | 601 | P48960 | |
| TLGREIQVARKGPCD | 521 | O00468 | |
| DGQVITIGNERFRCP | 246 | P62736 | |
| RDVTATNGCLPLGIR | 391 | Q8NCL9 | |
| RRAIVQDQGCLPGLI | 31 | Q9NVT9 | |
| SRILRTPQGCALLVG | 2841 | Q96DT5 | |
| GQVITIGNERFRCPE | 246 | P63267 | |
| GTLPVLNRRCVEAAV | 106 | O75879 | |
| RLAGFDGIVVCEVPN | 191 | Q8TF62 | |
| PRKFGVAGRSCQEVL | 16 | O76075 | |
| PELQRCLGIVGAQVA | 191 | Q96M86 | |
| EAVVRCLRVINPAVG | 36 | O60826 | |
| LEAIVSCCVGPEGRQ | 21 | Q8TAM1 | |
| VVCTVEQVRILRGLG | 121 | Q96NX9 | |
| RACELVQPNRGTVLA | 1211 | Q8IWY9 | |
| GLRERPVRCVEAQGS | 761 | Q76LX8 | |
| ADCAVAIGRPLGEVV | 1211 | Q76LX8 | |
| VIRRGGTCVVNPTDL | 196 | Q7Z6R9 | |
| ARCVHPRGGVIQSVS | 341 | Q96B23 | |
| VAALQGIRVQRVACG | 251 | O95199 | |
| SECNRQVGNIPGRLV | 1501 | A6NNM3 | |
| SECNRQVGNIPGRLV | 1501 | A6NJZ7 | |
| AVGARAGVVPSQLRV | 876 | O95153 | |
| CALQEVLRQVRLVPG | 166 | A6NJW4 | |
| KRPGAVLEAGCVVAR | 946 | O00763 | |
| CQEEAGPVRTAGLVA | 101 | O75808 | |
| GAVCVFEEAQGLPLR | 421 | O75106 | |
| VIREAGNGCEAISPV | 1051 | Q8TAB3 | |
| QVITIGNERFRCPEA | 946 | A5A3E0 | |
| SVARITCVRGQGPNE | 1006 | Q504Q3 | |
| PLDLACEFGRVGVVQ | 151 | Q8WXD9 | |
| EVIGKGPFSVVRRCI | 16 | O14936 | |
| LRGDINVCIVGDPST | 386 | Q14566 | |
| HPGVVIALVGACRRV | 401 | Q86U38 | |
| RINISEGNCPERIIT | 46 | Q15365 | |
| IANVVETIPCRGSAR | 201 | Q9NSA2 | |
| PAGVACDASRRIVVA | 656 | Q2Q1W2 | |
| PAQRCGRLEVGDLVL | 161 | Q9H6Y5 | |
| LCGGRVSQVPRQASI | 781 | Q8NEM0 | |
| EEFGRRIGDPQLVIC | 471 | Q9Y6K8 | |
| EGLRCVLIFGVPSRV | 71 | P13716 | |
| SGPIVSRATGRCLEV | 556 | Q9HCQ5 | |
| PGENARQLARIVCGT | 831 | P04035 | |
| VVRGSLVELPCEARG | 3426 | Q8NDA2 | |
| PLVRALEAGGCAVVR | 806 | Q76MJ5 | |
| PGVVVEDGVCIRRCT | 276 | Q9Y5P6 | |
| IQEIAGCRTVPVEVG | 226 | Q8N371 | |
| RGVEICIATPGRLID | 216 | P17844 | |
| QNIVRCVGLSLRATP | 571 | P29376 | |
| GVVAQRQPAGDRLCR | 66 | Q8NDV2 | |
| VLEGIRICRQGFPNR | 721 | Q7Z406 | |
| EVGLRVAGVRCNSIP | 871 | P51805 | |
| CVRGQNLDVVQTPRI | 1271 | O43157 | |
| ARLGRTVRLQCPVEG | 41 | Q8N441 | |
| GRGIDQCIPLFVEAA | 751 | O95373 | |
| EGRVRGCAVPSTVLL | 11 | Q96T54 | |
| PGCNIGEAIRVIAER | 241 | P06858 | |
| AEGTRDVPIGAIICI | 151 | P10515 | |
| VIREDCRGNILIPGL | 196 | Q14807 | |
| RVGPLLACIIGTQFR | 656 | P05164 | |
| EAIQGGIVRVNCSVP | 141 | P16284 | |
| LGLVGSEECIRVPRN | 116 | Q5GLZ8 | |
| REQVISVGSCVPLER | 176 | O14511 | |
| PRVETGGCTAVVLLV | 156 | Q8N819 | |
| RGQVPESIVCHGRVG | 411 | Q96LU7 | |
| AAQLCGPDRLRVAGE | 51 | Q9HD23 | |
| ICQTFVGRALQPVRD | 171 | P63132 | |
| LQGLGRLCERFPVVV | 486 | P42356 | |
| GAPGARAQLAVVCLV | 11 | O75074 | |
| KQALGRACGVSRPVI | 86 | P55769 | |
| IAQVTDCLPEFIGRG | 281 | Q9P2M1 | |
| SGCRTPQIEQAVGIV | 246 | P49281 | |
| VVPCVLSVNGDLDRG | 331 | Q9UHN1 | |
| DVGRGPTLELRQVCQ | 386 | Q9UHN1 | |
| GPEQLLRACEAITVG | 286 | P36915 | |
| RVLQEALCVISGVPG | 641 | Q92616 | |
| LVVAGLVRAQTCPSV | 36 | Q9HCJ2 | |
| QGRVRTLLECGVRPG | 251 | Q641Q3 | |
| RGIECDIRIQLPVVS | 31 | P46013 | |
| VAPGSVQCLAVLRDR | 1371 | Q9Y5S2 | |
| QGVRVPLLDSRTCDG | 181 | Q8NF86 | |
| NTRIICPGLRAGLAA | 716 | Q86XP1 | |
| GLRSPRQAAAVCAVL | 126 | Q9HC97 | |
| ICQTFVGRALQPVRE | 171 | P63135 | |
| ICQTFVGRALQPVRE | 171 | Q9BXR3 | |
| VAAPVLCGLNDVRGR | 166 | P21917 | |
| VPVNIGRAGACVVVV | 701 | Q9C0H6 | |
| ALCGFRGVAAQVLRP | 6 | O75306 | |
| GARINISEGNCPERI | 76 | P57721 | |
| RINISEGNCPERIIT | 46 | Q15366 | |
| NGVALRCFPGVVRSL | 531 | Q9NVE7 | |
| RRPQIQECVGFEISV | 56 | Q5T6X5 | |
| LVQIPCVIVERSQGG | 441 | Q8TCG2 | |
| VRVRLLVGCGLNTDP | 371 | Q96BZ4 | |
| QVITIGNERFRCPEA | 946 | Q6S8J3 | |
| QRPDLFGCVIAQVGV | 566 | P48147 | |
| GQLPLSGHCRVIVEV | 326 | Q9UN74 | |
| ICQTFVGRALQPVRD | 171 | Q9QC07 | |
| RLLQFVTGTCRLPVG | 826 | Q96J02 | |
| ERDRVVTNIDVPCGG | 4276 | Q8NCM8 | |
| CGETHIVVPLRERTG | 1246 | A4FU69 | |
| QCPVRLVTFIGVGRD | 356 | O95704 | |
| DGRRLQVGCAQVVPV | 181 | Q5EBM0 | |
| GLENEALIVRCPRQG | 26 | Q01638 | |
| RCLGAIITTVGPELQ | 1001 | Q9P2D3 | |
| VIEPRSGRVLQEANC | 206 | Q9UQ03 | |
| VLTVGQVQRGPCTAL | 46 | I3L3R5 | |
| LAGIQIRTNSCPIVR | 571 | Q86XK2 | |
| AVQCLTGPGQVARLV | 1016 | Q68DX3 | |
| VIVVGGAAEALLCRP | 181 | Q6ZPD8 | |
| LSGIQGVPLSRTVRC | 16 | P02778 | |
| GARTVPRVFIGKDCI | 66 | P35754 | |
| EGQRCVVILPDSVRN | 366 | P35520 | |
| LSAGPCRRAAQVLVQ | 26 | Q9NSI6 | |
| LGAGCREIVSLQVAP | 706 | Q8TF61 | |
| IREQGNGRLVCLLPS | 926 | Q9Y4F3 | |
| GSVLQRCIVSPAGRH | 6 | Q5VWZ2 | |
| ADLQVPRSGLAGCVV | 356 | Q14145 | |
| LVAGVPANLTCRSRG | 136 | Q6UWL6 | |
| GGLCIAQSVRIPQER | 246 | Q14831 | |
| RAQEGLRPGTLCTVA | 131 | P08311 | |
| LERGVEICIATPGRL | 291 | Q92841 | |
| AVGSECPSRVLVQVR | 536 | Q9Y4K1 | |
| AAIVCLRSQGLPEGR | 426 | Q9NX74 | |
| ELKRGAEIIVCTPGR | 491 | Q7L014 | |
| QGCDISPRSLSGRIV | 601 | P42261 | |
| PARVVQCISELGIFG | 416 | P48637 | |
| AGIRDGVVRPLKCTV | 1816 | P49327 | |
| IAPGAVVCVESEIRG | 11 | O00399 | |
| RGSIIISPCVVCRGA | 281 | Q96EY1 | |
| RLVNGGDRCQGRVEV | 1381 | Q9UGM3 | |
| GCRLPVRVEQVVNGA | 6 | Q6NUJ5 | |
| GPAEGTARVLLRQFC | 31 | O75880 | |
| DGQRIVGLIIPANCV | 1341 | A3KN83 | |
| VVVNRVDVARLPECG | 81 | O00411 | |
| EGCIRGERQSVPLDT | 716 | Q9BXL7 | |
| EGIRICRQGFPNRIV | 706 | P35580 | |
| RLGPDVSVGENCIIS | 436 | O14772 | |
| DSLPGQRLGDVIQRC | 306 | P00540 | |
| GRVGLNCPRLIELVV | 331 | Q9UKT6 | |
| QIGDIVTVGECRPLS | 121 | P62280 | |
| VIGVQPGDRCEVTVL | 86 | P0C091 | |
| ELRCRVAVEELSPGG | 16 | Q9H611 | |
| CLLQVDGEARARTGP | 291 | Q6ZW31 | |
| LEGIVVQRAECRPAA | 106 | P13984 | |
| PIGACVARIQALRQA | 1226 | A8K8P3 | |
| EVSRIPTVRGCNGSL | 11 | Q5JUK2 | |
| GDIQQVGVIRCPVCR | 171 | Q9UPN9 | |
| AAGGCEREPQSLTRV | 91 | O60260 | |
| VAQVCRVVPLVAGGI | 231 | P07988 | |
| RVIIQLPANGGRDCT | 801 | Q9UPZ6 | |
| CLGPERVAQLQDIAR | 1306 | Q8NDG6 | |
| RPTLRLELQGCEVNG | 2051 | P12259 | |
| RCGVPDVAQFVLTEG | 91 | P03956 | |
| VPEGRNVTFRCGQKI | 311 | O75900 | |
| SECNRQVGNIPGRLV | 1501 | Q9UFD9 | |
| VICVPTIRDIFGVIG | 391 | Q8WUX1 | |
| RRVEPVCSGLQAQIL | 191 | Q9BRQ6 | |
| DAQLATGGLVCPARR | 396 | P58107 | |
| RVLCLDCGEQTPRGV | 166 | Q9Y6E7 | |
| ACVIRGQVVAIDGTP | 886 | Q9UKZ4 | |
| VNIGAELIRCIVPTG | 1616 | P08F94 | |
| ELIRCIVPTGNGSVA | 1621 | P08F94 | |
| PLTGTLEVRVVGCRD | 321 | Q16512 | |
| IQEACARAGGRIAVP | 151 | Q8IWL1 | |
| TPEGLVVRCIQRLAE | 1191 | Q15477 | |
| TSACGVVVLRPARGA | 531 | Q9P2P6 | |
| IARQVGEGCRTVPLA | 6 | Q14141 | |
| IQEACARAGGRIAVP | 151 | Q8IWL2 | |
| ARGAQVIENCPVTGI | 226 | Q9UL12 | |
| QRTEGLGGERERQPC | 11 | O75908 | |
| ELRCPECRTLVGSGV | 46 | Q7Z6J0 | |
| DGQVITIGNERFRCP | 246 | P68032 | |
| LIQCIVFGPLRVSER | 101 | Q9UKV5 | |
| ANVACLRTGTVLIPG | 136 | Q53FZ2 | |
| VDVLSPVLGGACRQA | 426 | Q9UPV0 | |
| RRCAVLQATGGVEPA | 141 | Q86T13 | |
| GPQRCGIRTSDIIIL | 146 | Q9H8M5 | |
| VSPRAKEGGRQVICV | 201 | Q9H3H3 | |
| EGIRICRQGFPNRIV | 706 | P35749 | |
| ICQTFVGRALQPVRE | 171 | P63136 | |
| CRGTITELIPIEGRN | 481 | Q9BXT8 | |
| RASDTVVCEGRPQVL | 921 | O00562 | |
| VGGVLVEQCPARSEV | 31 | Q96HA9 | |
| CASVVLQVIERQGPR | 3226 | Q63HN8 | |
| GHVLGNPQRRDVVTC | 4556 | Q63HN8 | |
| VAIGVLRAKGETCPR | 66 | A6NLX4 | |
| VGPGSCRRQIIRALC | 6 | Q9HC57 | |
| ICQSRPDAIIVIGEG | 51 | P56706 | |
| QDCEVLGQRIPAGAV | 416 | P24557 | |
| VVARDVTGRQCPGLL | 66 | Q8NDQ6 | |
| DILRRCTVTAPGLAG | 1076 | Q9P217 | |
| LVVSVGCRSQGPNRE | 316 | Q6ZTK2 | |
| KGRVRCLTAGPEVAA | 286 | Q86XI8 | |
| GICFIRTSRPENAII | 466 | P29401 | |
| IGRVVCEAPTRLQGK | 236 | Q96PX8 | |
| VVPRCRGTAEALQIT | 396 | Q6ZMD2 | |
| RRLLEQVVSCGGLLP | 736 | Q96MK2 | |
| VVPEVCRRVCGTEVG | 346 | P31639 | |
| PAVGREVAQGLCDAI | 106 | Q6SZW1 | |
| NLRVRLGDVISIQPC | 91 | P55072 | |
| GPVNVVLRRIVQACV | 386 | Q9UQR0 | |
| LAIPVCAVRGRNVEN | 51 | Q99943 | |
| SVCRATGLGPVDRVE | 106 | O15067 | |
| GQCRQELARLVGARP | 471 | Q86SX3 | |
| ICQTFVGRALQPVRE | 171 | P10266 | |
| RDREVTRCGGLPNNI | 266 | O95551 | |
| ICQTFVGRALQPVRE | 171 | Q9UQG0 | |
| FVTLGAVPIIRCSRG | 201 | Q8WVM8 | |
| QGRLRPTVCGVEELR | 6 | Q96DC7 | |
| GLPEIRNVNGVDRLC | 146 | Q4G0T1 | |
| AVEQLRGCRVVGVIE | 146 | Q9Y6S9 | |
| CIIRLVAEFPATGGI | 246 | Q9NZM6 | |
| GGQTVRERLTERLCP | 366 | P27708 | |
| CRVPGQIEVLRGFLE | 281 | Q9Y577 | |
| SVVNVGCGPAEQRLL | 61 | Q96NS1 | |
| ICQSRPDAIIVIGEG | 51 | O00755 | |
| LVLVGFPQVLCVGTR | 2246 | O43149 | |
| CRVIRERVPEAQTGQ | 31 | Q9Y4G6 | |
| VGRLCVNDVGGQRIL | 266 | O15041 | |
| PRSVCGRLRQAAVLG | 421 | Q7Z403 | |
| CATQRAPGSVVELLG | 41 | O95363 | |
| LRRILCQVGLQEGPD | 331 | Q8IWV8 | |
| LVRSPGDSVIRQQCV | 1266 | Q69YN4 | |
| LVCGREDGSIVIVPA | 421 | Q9Y4E6 | |
| GSPGEVLSRRCVNLL | 2116 | Q9Y4A5 | |
| VVTVALRCPSGNVLR | 191 | O00124 | |
| GTVCRVQEPGAVLLA | 51 | Q9NYB0 | |
| VGSCDVRFPIRLEGL | 296 | Q6SJ96 | |
| QIADGDVCRGLSVPI | 236 | O14972 | |
| CAPAVVLGERIVIVG | 471 | Q2WGJ6 | |
| LGVPEEQLLGCRSRV | 6 | O94898 | |
| GIVLCEIIGRVNADP | 536 | P53667 | |
| VARGAPALLTCVNRG | 176 | Q9BRK3 | |
| RQFGRKPVVGQCTIE | 1381 | Q9NZM1 | |
| PEGTRVQLDCIVVGI | 281 | Q86TC9 |